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ABSTRACT 
 
  Mitochondria are the main sites for adenosine triphosphate (ATP) 
generation within most cells. Structural and functional alterations of mitochondria due to 
genetic abnormalities of mitochondria can cause respiratory chain dysfunction. In this 
study, the important role of mitochondria in energy metabolism was determined by 
comparing the effect of mitochondrial DNA (mtDNA) mutations on growth patterns and 
oxidative phosphorylation (OXPHOS) enzyme activities of six isolated clones (B5, B12, 
D4, D9, E1 and E8); as well as the effect of ATP supplement to culture using the slowest 
growing clone. The isolated clones had shown distinct growth pattern and morphology. 
The difference in proliferation rates among the clones was ascertained by the doubling 
times (B5=26.4h. B12=43.2h. D4=25.7h. D9=33.6h. E1=26.9h and E8=28.8h). The 
clone’s slow growth rate was likely the result of mitochondrial mutations in the 16S rRNA 
gene, ND1, ND4, ND6 and COX III. Five heteroplasmic mutations were found in clone 
B12 (G2480T, C2513G, A2520T, C9527T and C14263G), one heteroplasmic mutation in 
clone D9 (A4137G) and one homoplasmic mutation in clone D4 (C11496). The mutations 
in clone B12 appeared to be deleterious to the cell by disrupting mitochondrial OXPHOS 
activities and reducing energy output. Additionally, extracellular ATP supplement to 
OXPHOS deficient clone B12 facilitated cell growth and enhances the gene expression. 
Increased expression of mtDNA-encoded respiratory chain complexes observed in clone 
B12 compared to clone D4 may reflect mitochondrial genomic adaptation to perturbations 
in cellular energy requirements. The stimulation of mitochondrial biogenesis may be a 
cellular response in compensation for defects in OXPHOS associated with mtDNA 
mutations. My data support the hypothesis that the variability in functional manifestations 
of mtDNA is attributed to the nature of the mutation, number of mutation and the gene 
specifically affected. These results will help to further our understanding of the 
relationship between mitochondrial mutation and cellular function. 
 
Keywords: MCF-7, cell doubling time, mitochondrial DNA mutation, OXPHOS defect, 
ATP, gene expression 
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1.1.  The mitochondrion 
 
  Mitochondria have been extensively studied in the past decades. These 
membrane-bound cytoplasmic organelles have received ample interest from researchers 
from different scientific fields due to their function and remarkably unique properties. 
Mitochondria have a pivotal role in cellular energy metabolism, being the major site of 
ATP synthesis via oxidative phosphorylation (OXPHOS). This chapter will briefly 
review current understanding of the structure and function of mitochondria, as well as 
the effect of mitochondrial DNA (mtDNA) mutation on their oxidative potential and 
ATP production which ultimately lead to a myriad of diseases. 
 
 
1.1.1.  Background 
 
  According to the endosymbiotic theory of Gray et al. (1999), double-
membraned mitochondria are evolved from facilitated aerobic bacteria. Their closest 
living relatives, based on ribosomal RNA comparisons are the α-proteobacteria (in 
particular Rickettsia). Gray et al. (1999) suggested that mitochondria originated as 
separate prokaryotic organisms, which were engulfed by a nucleus-containing host cell 
without being digested. When they became incorporated into the cytoplasm, the 
mitochondria developed a symbiotic relationship with the host cell. The outer 
membrane represents the plasma membrane of the ancestral feeder host cell; the inner 
membrane corresponds to the plasma membrane of the ancestral endosymbiont. Several 
lines of evidence supporting the theory include: (1) The genome of mitochondria reside 
within a single, circular DNA molecule that is devoid of histone proteins, which 
resemble bacterial genophores. (2) Mitochondrial ribosomes are about the same size as 
those in bacteria. (3) Mitochondria reproduce asexually in a manner resembling binary 
fission in bacteria. (4) As in bacteria, mitochondrial genomes encode rRNA and tRNA 
for their own protein synthesis. 
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1.1.2.  Structure 
 
  Mitochondria are bounded by two membranes separated by a narrow 
fluid-filled space. The outer membrane contains specialised transport proteins called 
porins, which allow passage of molecules with molecular weights as high as 10,000 
dalton into the intermembrane space. The inner membrane is highly impermeable to 
small ions due to the high concentration of a phospholipid, cardiolipin. The inner 
membrane is highly folded into irregular series of partitions called cristae. The cristae 
protrude into the central space of the mitochondrion, the matrix (Fig. 1.1). The cristae 
increase the surface area for reactions that depend upon the creation of a proton 
gradient across the cristae. They are the sites of the enzymes of aerobic respiration and 
ATP production. The matrix consists of numerous compounds such as proteins, lipid 
and nucleic acid. All mitochondria contain multiple copies of their genomes in the 
matrix (Campbell and Reece, 2002).  
 
 
 
 
Figure 1.1. Electron micrograph and diagram showing the structure of a mitochondrion.  
Adapted from Purves et al. (1994). 
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  There are several unique characteristics of mitochondria that could 
contribute to the pathogenesis of diseases associated with defects in mitochondrial 
genome. Current understanding of mitochondrial genetics include: (1) maternal 
inheritance, (2) mitotic segregation, (3) high mutation rate in mtDNA, (4) heteroplasmy, 
(5) threshold effect in phenotypic expression of mutant mtDNA, and (6) accumulation 
of somatic mtDNA mutations in aging and degenerative diseases (Schon, 2000; Pulkes 
and Hanna, 2001).  
 
 
1.1.3.  Functions 
 
  Mitochondria generate cellular energy in the form of adenosine 
triphosphate (ATP) via the process of oxidative phosphorylation (OXPHOS). The 
energy-producing pathway consists of the proton-translocating respiratory chain 
complexes I, III and IV, the proton-utilising ATP synthase (complex V), and a set of 
accessory complexes that supply electrons to coenzyme Q (ubiquinone), including 
complex II, the electron-transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO), 
and dihydroorotate dehydrogenase (Smeitink et al., 2006) (Fig. 1.2). These OXPHOS 
components are located within the mitochondrial inner membrane. 
 
  Pyruvate, which is generated by glycolysis in the cytosol, enters 
mitochondria when oxygen is available. It is then enzymatically converted to acetyl 
coenzyme A (acetyl CoA) and carbon dioxide. Acetyl CoA enters the Krebs cycle in 
the matrix of mitochondria. Coenzymes such as flavin adenine dinucleotide (FAD) and 
nicotinamide adenine dinucleotide (NAD) serve as electron carriers, which transfer 
electrons to ubiquinone in the respiratory chain. Together with cytochromes, they make 
up an electron transport chain. This coupled series of oxidation-reduction (redox) 
reactions passes electrons from hydrogen atoms along the membrane-bound carrier 
molecules. Most of the energy decrease at each of the three redox steps of the electron 
cascade of mitochondria is used to synthesise ATP, whereas the remainder energy is 
lost as heat. Oxygen is the final acceptor of hydrogen ions and electrons; water is the 
end product of this electron cascade. Several molecules of ATP are synthesised from 
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ADP along this pathway. The net energy yield from oxidative respiration may be as 
high as 38 ATP molecules per molecule of glucose (two each by substrate-level 
phosphorylation during glycolysis and the Krebs cycle; 34 from oxidative 
phosphorylation via the electron transport chain).  
 
 
   
 
 
Figure 1.2. Mitochondrial respiratory chain. NADH, reduced form of nicotinamide adenine 
dinucleotide; Q, coenzyme Q (ubiquinone); c, cytochrome c; H+, proton; ADP, adenosine 
diphosphate; ATP, adenosine triphosphate. The direction of protons and electron flux and are 
indicated by arrows. All five enzymatic multi-heteromeric complexes (I, II, III, IV and V) are 
embedded in the inner membrane of mitochondria. Reducing equivalents from the tricarboxylic 
acid cycle are transferred to OXPHOS as NADH (at complex I), or reduced flavins (entering at 
complex II). Coenzyme Q and cytochrome c serve as electron shuttles between the complexes. 
Adapted from Hanna and Nelson (1999). 
 
Chapter 1 INTRODUCTION 
 
 
5 
  The respiratory chain transfers electrons from reduced substrates down a 
stepwise energy gradient, finally to molecular oxygen to form water. The energy 
released is used by complexes I, III and IV to pump protons (H
+
) out of the 
mitochondrial matrix into the intermembrane space. A proton electrochemical potential 
gradient is generated across the inner mitochondrial membrane. This proton motive 
force (PMF) is harnessed by complex V (ATP synthase), which is essentially an ATP-
hydrolysing pump, to synthesise adenosine triphosphate (ATP) from adenosine 
diphosphate (ADP) and inorganic phosphate (Pi) (Chinnery and Schon, 2003). Some of 
the matrix ATP is used for the mitochondrion’s own needs, but most of it is transported 
outside the organelle by the adenine nucleotide translocator (ANT) and used for diverse 
cell functions (Hatefi, 1985). 
 
 
1.1.4.  Mitochondrial DNA (mtDNA)  
 
(i)  Structure and functions 
 
  The human mitochondrial genome is a circular molecule consisting of 
16,569 base pairs (bp) of nucleotides. There are multiple copies of mitochondrial DNA 
(mtDNA) in each mitochondrion. They are located in the mitochondrial matrix. All of 
the coding sequences are contiguous with each other, and the coding regions have no 
introns. There is a non-coding region of 1124 bp, the displacement-loop (D-loop), 
which contains regulatory sequences controlling both transcription and replication of 
mtDNA (Anderson et al., 1981). The D-loop, the hypervariable region, is most prone to 
mutation. There are two complementary DNA strands the heavy (OH) and light (OL) 
strands, which can be distinguished by their density. The OL strand is rich in cytosines, 
and the OH strand is rich in guanines. The origin of replication of the heavy strand (OH) 
is located in the D-loop, whereas the origin of replication of the light strand (OL) is 
located farther on the genome. Transcription takes place in opposite directions for the 
two strands starting from their respective promoters (Baggetto, 1993). The OL strand 
serves as the template for the continuous synthesis of a new OH strand, an origin of 
replication site that corresponds to a transcriptional promoter on the light chain (Klug 
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and Cummings, 2000). The OH strand gives polycistronic RNAs that are subsequently 
matured by endonucleolytic cleavages upstream and downstream of the tRNA 
sequences (Tan et al., 2002). Ribosomal RNAs are then modified post-transcriptionally 
by the addition of short adenyl stretches, whereas the mitochondrial mRNAs are 
polyadenylated by a mitochondrial poly(A) polymerase during or immediately after 
cleavage (Ojala et al., 1981). As mtDNA uses a different genetic code from nuclear 
DNA, mitochondrial mRNA cannot be translated in the cytosol (Anderson et al., 1981). 
 
  The mtDNA encodes for 37 genes that are involved in cellular energy 
production.  These 37 genes include 13 of the ~85 polypeptides comprising the 
OXPHOS complexes (subunits of complexes I, III, IV, and V), along with two rRNAs 
and 22 tRNAs that are required for their translation (Anderson et al., 1981) (Fig. 1.3). 
Complex I or NADH-ubiquinone oxidoreductase, which accomplishes the oxidation of 
NADH derived by the oxidation of pyruvate, contains seven subunits (ND1-ND6 and 
ND4L) and at least 30 nuclear-encoded subunits (Smeitink et al., 2001). Complex II or 
succinate-ubiquinone oxidoreductase, which accomplishes the oxidation of FADH2 
derived from fatty acid and the Krebs’ cycle, is composed of four nuclear-encoded 
subunits. Complex III or ubiquinol-ferricytochrome c oxidoreductase, which catalyses 
the transfer of two electrons from ubiquinol to ferricytochrome c, holds one mtDNA 
encoded subunit (cytochrome b) and 10 subunits encoded by the nuclear genome. 
Complex IV or cytochrome c oxidase (COX) catalyses electron transfer from 
cytochrome c to molecular oxygen and pumps protons to the intermembrane space. 
Complex IV consists of three mtDNA encoded subunits (COX I-III) and other 10 by 
nuclear DNA. Complex V or ATP synthase (ATPase) acts as a rotary motor coupled 
proton gradient generated by the respiratory chain to phosphorylate matrix ADP. 
Complex V is composed of two mtDNA encoded subunits (ATPase 6 and 8), plus 14 
nuclear DNA encoded subunits (Zeviani and Di Donato, 2004). Table 1.1 summarises 
the composition of the five mitochondrial membrane-bound enzyme complexes that are 
involved in OXPHOS. The degree of impairment of the complexes usually matches 
their content of mitochondrially encoded components: complex I > complex IV > 
complex V > complex III (James and Murphy, 2002). In addition, the other OXPHOS 
polypeptides, and proteins involved in mtDNA maintenance and expression are all 
Chapter 1 INTRODUCTION 
 
 
7 
encoded by the nuclear genome. These components are synthesised in the cytoplasm 
and imported into the mitochondria (Chinnery and Schon, 2003).  
 
 
 
 
 
 
 
Figure 1.3. Human mitochondrial genome. Protein-coding genes: seven subunits of NADH 
dehydrogenase-CoQ oxidoreductase (ND); one subunit of CoQ-cytochrome c oxidoreductase 
(Cyt b); three subunits of cytochrome c oxidase (COX); and two subunits of ATP synthase (A). 
Protein synthesis genes: 12S, 16S rRNAs and tRNAs (indicated by black lines and denoted by 
their single letter code). Mitochondrially encoded subunits are shown in different colours: 
complex I = blue; complex III = green; complex IV = red; complex V = yellow; 12S and 16S 
rRNA = purple. OH and OL, the origins of heavy and light strand mtDNA replication. 
Adapted from Taylor and Turnbull (2005). 
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Table 1.1. Composition of the respiratory chain and oxidative phosphorylation system. 
Adapted from Penta et al. (2001). 
  
Complex Total no. subunits No. subunits encoded by mtDNA 
I 43               7    (ND 1-6, ND4L) 
II 4               0 
III 11               1    (cytochrome b) 
IV 13               3    (COX I, II, III) 
V 16               2    (ATPase 6 and 8) 
 
 
(ii)  Differences from nuclear DNA 
  
  The genetic code of mitochondrial differs slightly from the nuclear 
genetic code (Table 1.2). Mitochondrial genes, which lack a termination codon, are 
overcome by the insertion of UAA at the transcriptional level. Since the mtDNA 
genetic code differs from the universal code, expression of mtDNA genes must rely 
upon mitochondrion-specific protein synthesis, which is carried out through the 
interplay of nuclear-encoded transcriptional, and translational factors with rRNAs and 
tRNAs synthesised from the corresponding mitochondrial genes (Zeviani and Di 
Donato, 2004).  
 
 
Table 1.2. Differences in genetic code between mitochondrial genome and nuclear genome. 
  
Codon Mitochondrial genome Nuclear genome 
AGA STOP Arginine 
AGG STOP Arginine 
AUA START (Methionine) Isoleucine 
UGA Tryptophan STOP 
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  Unlike nuclear DNA replication that occurs only during the S phase, 
replication of mitochondrial DNA is not restricted to the S phase of the cell cycle, but 
can occur during all stages of interphase (G1  S  G2). It replicates rapidly without 
efficient proofreading, DNA repair mechanisms, and the protection of DNA-binding 
proteins such as histones (Brown and Wallace, 1994; Klug and Cummings, 2000). 
These factors are thought to contribute to the high mutation rate of mtDNA, which is 
about 10 times higher than that of nuclear DNA (cited in Snustad and Simmons, 2003). 
However, recent studies have shown that mtDNA do have proofreading ability through 
human DNA polymerase gamma (Ropp and Copeland, 1996; Longley et al., 2001). 
 
 
1.2.   Mitochondrial disorders 
 
1.2.1.  Mitochondrial diseases 
 
  Mutations of the mitochondrial genome causing respiratory dysfunction 
are responsible for a wide variety of mitochondrial diseases (Schon et al., 1997). 
Because the mtDNA mutation rate is high, mtDNA diseases appear to be common. 
These diseases may be present at any time from the neonatal period to late adult life. 
The phenotypic effects of mitochondrial mutations reflect the extent to which a tissue 
relies on oxidative metabolism. Therefore, mitochondrial disorders most commonly 
manifest themselves in tissues such as the brain, the heart, skeletal muscle, nerves, 
renal and the endocrine systems that are highly dependent on biological energy 
(Wallace, 1999, 2000; Pulkes and Hanna, 2001). The majority of patients with 
mitochondrial disease have significant neuropathology, with the most common features 
being spongiform degeneration, neuronal loss and gliosis, as well as loss of vision, 
hearing impairment, epilepsy, deficiencies of skeletal and cardiac muscle function or 
diabetes (Pulkes and Hanna, 2001). Furthermore, OXPHOS defects may also affect 
various cellular properties, such as mitochondrial membrane potential in myoclonus 
epilepsy with ragged red fibres (MERRF); mitochondrial encephalopathy, lactic 
acidosis and stroke like episodes (MELAS) (James et al., 1996); ATP/ADP ratio 
(James et al., 1999), reactive oxygen species (ROS) production (Luo et al., 1997) and 
mitochondrial calcium homeostasis (Brini et al., 1999).  
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  Each human cell contains numerous mitochondria and each 
mitochondrion contains approximately 10 to 100 mtDNA molecules (Schuster et al., 
1988). Variant mixtures of mutant or partially deleted mitochondria often exist in cells 
that also contain normal mitochondria: a state known as heteroplasmy. Pathogenic 
mtDNA mutations are expressed according to a threshold effect. There may be a 
mixture of respiratory competent and deficient cells within a tissue, in which a 
threshold mutation level is required to develop a biochemical respiratory chain defect 
in individual cells (Taylor and Turnbull, 2005). For instance, in wild-types, when their 
mutation tolerance levels fall below a critical value, at which point they can no longer 
compensate for the effect of the mutation, impairment of mitochondrial function is 
likely to occur. The precise threshold for biochemical expression varies from mutation 
to mutation, and from tissue to tissue. Retrospective studies have shown that the 
percentage level of mutated mtDNA in clinically relevant tissues does correlate with 
the severity of disease (Chinnery et al., 1997).  
 
  Rossignol et al. (2003) postulated that, in the absence of mutations, 
there is an excess of mRNAs, tRNAs and active respiratory chain complexes compared 
with what is required to permit `normal' respiration. Genetic and functional 
complementation can occur at different levels of gene expression in mitochondria 
depending on the gene affected by the mutation in mtDNA. They suggested that the 
effect of a mutation can be complemented at either transcription or translation level; 
during OXPHOS enzyme activity and ATP synthesis; or even cell growth.  
 
  The OXPHOS system is under dual genetic control, thus, mutations in 
either mitochondrial or nuclear genomes can lead to mitochondrial dysfunction. 
However, due to the high mutation rate of mtDNA and the vast number of nuclear 
genes involved, molecular diagnosis of mtDNA disorders has been focused on mtDNA 
mutation. There are two main types of mtDNA mutations, those that affect 
mitochondrial protein synthesis and those in protein-coding genes (DiMauro and Schon, 
2001). Thus, five criteria are required to prove that a mtDNA mutation is pathogenic: 
(1) The mutation must be specific and not associated with other disease-causing 
mutations. (2) The mutation results in a change of a conserved nucleotide base or 
amino acid residue, which alters a functional protein. (3) Deleterious mutations are 
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usually heteroplasmic. (4) The mutation segregates with the disease clinically. (5) The 
mutation segregates with the disease biochemically (Riordan-Eva and Harding, 1995; 
Chinnery and Schon, 2003). In the past 18 years, more than 100 point mutations or 
large scale rearrangements (deletions and duplications) of mtDNA have been 
associated with human mitochondrial disease (e.g. Wallace, 2000; Chinnery et al., 
2000a).  
 
 
1.2.2.  mtDNA mutation and male infertility 
 
  Mitochondria also play an important role in spermatozoa functionality 
due to the high ATP demand of these cells. Previous findings suggest that mtDNA 
mutations are associated with diminished fertility and motility of human spermatozoa 
(Frank and Hurst 1996; Kao et al., 1995, 1998; Ruiz-Pesini et al., 1998, 2000; 
Holyoake et al., 1999; St. John et al., 2000). Single nucleotide polymorphisms (SNPs) 
can also compromise semen quality (Holyoake et al., 2001). There may be many 
descriptions of pathophysiological changes as a result of mtDNA mutation. But little is 
known about its relevance to sperm number and sperm function. The human testis 
manufactures over 100 million sperm cells daily. The process of spermatogenesis is 
divided into three stages: mitosis, meiosis and spermiogenesis. All these stages require 
ATP to ensure efficient cell replication as cells need the energy to divide. Thus, it has 
been hypothesised that mtDNA mutation affects ATP production and can lead to a 
reduction in sperm count.  
 
 
1.2.3.  Mitochondria in aging and neurodegeneration 
 
  Mitochondrion is increasingly recognised as playing an important role in 
both aging and neurodegenerative diseases. Previous studies have shown that the 
accumulation of mtDNA mutations accelerates normal aging, results in oxidative 
damage to nuclear DNA, thus, impairing gene transcription. There is considerable 
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evidence from studies of animal models that mitochondrial dysfunction may contribute 
to the pathogenesis of neurodegenerative diseases, such as Alzheimer’s disease, 
Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, hereditary 
spastic paraplegia, and cerebellar degenerations (for review see Beal, 2005). For 
example, oxidative damage to lipids has been shown to precede β-amyloid deposition 
in Alzheimer’s disease in transgenic mice (Pratico et al., 2001). The mitochondria 
generate most of the cellular reactive oxygen species (ROS) as a toxic by-product of 
OXPHOS, resulting in oxidative damage to mitochondrial and cellular proteins, lipids, 
and nucleic acids (Chance et al., 1979; Floyd and Carney, 1992). Brain is particularly 
susceptible to oxidative damage because it is enriched in the more easily peroxidisable 
fatty acids, and has a relative deficit of antioxidant defence systems (Floyd, 1999). In 
Parkinson’s disease, mutation in DJ-1, a protein that participates in the oxidative stress 
response in mitochondria, renders nerve cells more vulnerable to oxidative damage 
(Taira et al., 2004). 
 
 
1.2.4.  Mitochondrial DNA in human malignancy 
 
  Alterations in the enzymatic complexes which impede the OXPHOS 
system have been reported in solid tumours such as breast, colon, stomach, liver, 
kidney, bladder, prostate, lung, head and neck, and in hematologic malignancies such 
as leukaemia, myelodysplastic syndrome (MDS) and lymphoma (for review see Penta 
et al., 2001). Although the exact mechanism is still not well-documented, there is 
considerable evidence suggesting that mitochondria may serve as contributors to 
carcinogenesis (Shay and Werbin, 1987; Baggetto, 1993; Cavelli and Liang, 1998). 
Thus, an increasing number of laboratories have investigated mtDNA as a potential 
marker for tumourigenesis in various types of tissues (Sanchez-Cespedes et al., 2001; 
Wong et al., 2003). 
 
   Oxidative damage has been implicated in human carcinogenesis 
(Poulsen et al., 1998).
 
It is believed that mtDNA mutations and respiratory dysfunction 
may be linked directly to carcinogenesis via ROS and apoptotic-mediated pathways 
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(Cavalli and Liang, 1998). mtDNA is located in the mitochondrial matrix in close 
proximity to the electron transport system where ROS, such as superoxide anions, 
hydrogen peroxide and hydroxyl radicals, are continuously generated. Mutations in 
mtDNA may lead to a decreased efficiency of the electron transport chain and an 
increased leakage of electrons at this site. This may result in increased generation of 
mitochondrial and cellular ROS, creating oxidative stress and damaging to lipid 
membranes and other cellular constituents, thereby favouring the neoplastic process 
(Sawyer and Van Houten, 1999). Moreover, most mtDNA mutations occur in coding 
sequences because mtDNA lacks introns. Also, due to the lacking of protective histones 
and effective DNA repair capabilities, the mitochondrial genome is highly susceptible 
to oxidative damage and ultimately leads to mutations (Mecocci et al., 1993). It is 
proven that mutations induced by oxidative damage contribute
 
significantly to genetic 
instability in tumours and thereby promote a higher propensity for tumour progression 
(Zienolddiny et al., 2000).  Hence, there is a higher possibility that the high mutation 
rate of mtDNA may worsen oxidative stress or vice versa.  
 
  In addition, Shay and Werbin (1987) proposed that a mitochondrial 
factor in combination with a nuclear gene, code for a suppressor of tumorigenicity. A 
gradual reduction in the number of mitochondria during the progression stage of 
carcinogenesis would lead to a simultaneous reduction in the cytoplasmic suppressor. 
As a result, there is a gradual activation of a mutated oncogene and the onset of the 
tumorigenic phenotype.   
 
  Recent studies have also demonstrated a relationship between nucleus-
encoded mitochondrial succinate dehyrogenase (SDH) and cancer (Selak et al., 2005). 
SDH is a component of the OXPHOS complexes I-IV and tricarboxylic acid cycle 
(TCA), as well as a tumour suppressor. Deficiency of SDH may lead to the 
accumulation of succinate intramitochondrally. The increased concentration of 
succinate will inhibit prolyl hydroxylases (PHD), hence the degradation of hypoxia-
inducible factor (HIF-1α). The elevated HIF activity may induce the transcription of 
nuclear genes that facilitate angiogenesis, metastasis, and glycolysis, ultimately leading 
to tumour progression.  
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1.3.   Effect of extracellular ATP on cell proliferation  
 
  ATP is a physiological compound present in all cells. ATP can be 
released in the extracellular space by many cell types, such as platelets, adrenal 
chromaffin, endothelial cells and injured cells, via secretory exocytosis and carrier-
mediated mechanisms. Extracellular ATP can influence many biological processes 
including platelet aggregation, vascular tone, neurotransmission, skeletal and smooth 
muscle contraction, endocrine/exocrine secretion, inflammation, wound healing, 
immune response, pulmonary and cardiac function, and cell growth (for review see 
Gordon, 1986). Extracellular ATP functions by interacting with plasma membrane 
nucleotide receptors (Rathbone et al., 1992; Abbracchio and Burnstock, 1994). In 
addition to its many intracellular functions, ATP may act as a potent extracellular 
messenger, mediating the coupling of purinergic (P2) receptors to different 
pathophysiological functions such as cell proliferation, differentiation and apoptosis 
(White and Burnstock, 2006). The term ‘purinoceptor’ is now generally used for such 
nucleotide receptors.  
 
  Several studies using pharmacological approach have recently 
demonstrated a close relationship between ATP and the proliferative activities of 
mammalian cultured cells, such as rat astrocytes (Hindley et al., 1994), mouse 
fibroblast (Huang et al., 1989), human astrocytoma, porcine aortic smooth muscle cells 
(Wang et al., 1992),  rat renal mesangial cells (Schulze-Lohoff et al., 1992, 1995, 1996, 
1998; Huwiler and Pfeilschifter, 1994), rat proximal tubule epithelial cells (Paller et al., 
1998), human ovarian cancer cells (Popper and Batra, 1993; Batra and Fadeel, 1994; 
Schultze-Mosgau et al., 2000),  breast cancer cells (Dixon et al., 1997), human 
intestinal epithelial cancer cells (Coutinho-Silva et al., 2005), and human endometrial 
cancer cells (Katzur et al., 1999). Abbracchio and Burnstock (1994) proposed that there 
are three major P2 purinoceptor classes based on agonist selectivity and signaling 
properties: ionotropic P2X, metabotropic P2Y and P2Z (Table 1.3). Each of these 
classes of receptors is composed of several subtypes. P2Z is later known as P2X7. 
Currently, seven P2X and eight P2Y receptor subtypes have been characterized (White 
and Burnstock, 2006). 
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  The P2X purinoreceptors are ATP-regulated non-selective cation 
channels permeable to Na
+
, K
+
 and Ca
2+
 (Bean, 1992).  On prolonged exposure of 
cultured mesangial cells to high concentration of ATP, the cation channel can be 
converted to a large nonselective transmembrane pore allowing the passage of larger 
molecules, facilitating apoptosis and necrosis (Schulze-Lohoff et al., 1998). This effect 
is associated with apoptosis mediated through the caspase enzyme system (Humphreys 
et al., 2000). 
 
 
Table 1.3. Proposed subclassification of P2 purinoceptors. Adapted from 
Abbracchio and Burnstock (1994). 
 
Name P2X P2Y P2Z 
Type Ligand-gated channel 
(Na
+
, K
+
, Ca
2+
) 
G-protein coupled 
([Ca
2+
]I, IP3, DAG) 
Non-selective pore 
General agonist ATP/ADP/UTP ATP/ADP/AMP/UTP ATP 
 
   
  P2Y has been predicted to possess characteristics of G-protein-coupled 
receptors: an N-terminal extracellular domain with two consensus sites for N-linked 
glycosylation, seven hydrophobic putative transmembrane α-helices, and a large C-
terminal intracellular domain containing several consensus phosphorylation sites. 
(Barnard et al., 1994). P2Y modulates a primary signal transduction pathway through 
activation of phospholipase C (PLC), which leads to the formation of inositol 1,4,5-
trisphosphate (IP3) and diacyle-glycerol (DAG) generation (Cusack, 1993), as well as 
regulating mobilisation of intracellular Ca
2+
 from the endoplasmic reticulum (White et 
al., 2005). P2Y is also involved in secondary signalling pathways including the 
inhibition and stimulation of adenylyl cyclase (AC) (White and Burnstock, 2006).  
 
  ATP also appears to co-ordinately regulate protein synthesis, DNA 
synthesis, and expression of immediate-early genes. It has been shown previously that 
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extracellular ATP stimulated phosphorylation and activation of mitogen-activated 
protein kinase (MAPK) and increased expression of the immediate early genes, which 
include proto-oncogenes c-fos, c-jun and Egr-1 via specific P2Y receptors (Huwiler 
and Pfeilschifter, 1994; Schulze-Lohoff et al., 1996). Soltoff et al. (1998) further 
demonstrated that the activation of G-protein-coupled P2Y2 receptors by extracellular 
ATP and UTP stimulated MAPK by a mechanism that was dependent on the elevation 
of intracellular Ca
2+
 and the activation of related adhesion focal tyrosine kinase 
(RAFTK) and protein kinase C (PKC).   
 
  P2Z receptors are present on mast cells, macrophages, and fibroblasts. 
Falzoni et al. (1995) reported that the P2Z receptor was expressed during macrophage 
differentiation and upregulated by an inflammatory cytokine such as IFN-y. These 
findings suggested that P2Z receptors may have an important role in macrophage 
physiology. Additionally, Saribas et al. (1993) reported that exogenous ATP could alter 
the membrane permeability of mouse fibroblasts through the interaction with P2Z 
receptors. Activation of the P2Z receptor could also promote apoptosis via the opening 
of large plasma membrane pores (Pizzo et al., 1992). Nevertheless, the function of P2Z 
is still less well understood.  
 
  Recent researches have presented evidence on the functional roles of 
P2Y and P2X receptors on carcinoma cells from different tissues. Rapaport (1983) 
demonstrated that low levels of extracellular ATP significantly inhibit the growth of 
human tumor cells (CAPAN-1, a pancreatic adenocarcinoma; HT29, a colon 
adenocarcinoma) in vitro. Such antiproliferative actions of ATP were also observed in 
endometrial cancer cells (Katzur et al., 1999) and human ovarian cancer cells 
(Schultze-Mosgau et al., 2000). Conversely, ATP can also exert mitogenic effect on 
many cancer cells through the stimulation of P2Y receptors (Wang et al., 1992; 
Schulze-Lohoff et al., 1992, 1995, 1996; Popper and Batra, 1993; Hindley et al., 1994; 
Huwiler and Pfeilschifter, 1994; Dixon et al., 1997; Paller et al., 1998; Wagstaff et al., 
2000; White et al., 2005). It is likely that these actions depend on the receptor subtype 
in a particular tissue and the activated intracellular signalling pathways. Figure 1.4 
summarises the possible modes of action of P2 receptors on cancer cells.  
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Fig. 1.4. Alteration in cancer cell function by different modes of action of P2 receptor 
subtypes. Adapted from White and Burnstock (2006). Abbreviations: AC, adenylyl cyclase; 
DAG, diacylglycerol; Ins(1,4,5)P3, inositol (1,4,5)-trisphosphate; PLC, phospholipase C; 
PtdIns(4,5)P2, phosphatidylinositol (4,5)-bisphosphate. 
 
 
1.4.   Other effect of ATP 
 
  Sperm mitochondria play an important role in spermatozoa because of 
the high ATP demand of these cells. Therefore, any alterations in mtDNA may have 
consequences for normal fertilisation. This is supported by the findings of Díez-
Sánchez et al. (2003), which demonstrated a marked increase of mtDNA copy number 
per cell volume during spermatogenesis. It is also reported previously that oxidative 
phosphorylation activity is variable depending on the mitochondrial genetic 
background and is correlated with sperm motility (Ruiz-Pesini et al., 1998, 2000). 
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These observations lead to the question of how mtDNA variability could affect sperm 
function. Additionally, ATP is a potent inducer of acrosome reaction and capacitation 
in human spermatozoa (Foresta et al., 1992, 1996c). Sperm incubation with 
extracellular ATP induced a significant increase of fertilization rate in in vitro 
fertilisation for male factor infertility (Rossato et al., 1999). 
 
 
1.5.  MCF-7 cell line 
 
  MCF-7 cell line was established from the pleural effusion of a patient 
who was diagnosed with adenocarcinoma of the breast (Soule et al. 1973). This cell 
line has been shown by Resnicoff et al. (1987) to be highly heterogeneous with the 
ability to generate clonal variability. These findings showed an existence of several 
sublines which possessed different properties including growth rate and gene 
expression. On the other hand, Wagstaff et al. (2000) demonstrated that extracellular 
ATP potentiates growth factor-induced c-fos expression in MCF-7 cells resulted from 
P2Y receptor activation, which induced multiple signaling pathways. Cell proliferation 
is associated with ATP and mediated by a complex intracellular signaling network 
whose disruption is strongly linked to neoplastic transformation. However, there is little 
known about the relevance of mtDNA mutation in the performance of OXPHOS 
enzymes and on MCF-7 growth characteristics.  Thus, MCF-7 cells will provide an 
excellent in vitro model system for research into the relationship between 
mitochondrial mutations and biochemical changes that may attribute to the growth 
characteristics of different sublines of MCF-7. The present study aims to improve our 
understanding of the effect of mtDNA mutation on MCF-7 cell line that is previously 
not well established. 
 
 
1.6.  Hypothesis 
 
  On the basis of the aforementioned genetics and biochemical functions 
of mitochondria, it is evident that normal mitochondrial function is vital for cell 
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function. The aim of this study was to investigate the relationship between 
mitochondrial mutation and cell proliferation. In this study, it is proposed that any 
mutation that alters a functional gene in mtDNA is likely to affect OXPHOS and ATP 
production, and the number of mutations may be associated with the severity of the 
respiratory chain impairment. It is also purported that extracellular ATP supplement to 
OXPHOS deficient cells may facilitate cell growth and enhances the gene expression. 
Such a model promises to recapitulate the genetic and physiological variation seen in 
mitochondrial diseases and may ultimately provide important new insights into the role 
of mitochondrial defects in a spectrum of progressive diseases. 
 
 
1.7.   Aims of research 
 
(1) To use a breast cancer cell line MCF-7, as a model to study the basic function of 
mitochondria, the pathogenetic mechanisms that underlie normal and abnormal 
respiratory chain functions. 
 
(2) To identify mutations in genes encoded by mtDNA and characterise these 
mutations by DNA sequencing. 
 
(3) To investigate the effect of mitochondrial mutation on the enzymes of oxidative 
phosphorylation and establish a relationship between OXPHOS function and 
growth pattern. 
 
(4)       To investigate the effect of extracellular ATP on cell growth and gene 
activation. 
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2.1.   Materials 
 
The chemicals used in this study were of analytical grade. The 
chemicals with suppliers and abbreviations are listed in the text. All chemicals were 
obtained from BDH Chemicals (Poole, England) unless otherwise indicated. The water 
used in all experiments was purified by a NANOpure ultra-filtration system (Millipore, 
USA). Then the water was sterilised by autoclaving before use, and expressed as 
ddH2O. The recipes for some preparations are shown in Appendix 2. 
 
 
2.2.  Methods 
 
2.2.1.  Cell culture 
 
An MCF-7 cell line (passage 138), a stable cell line derived by pleural 
effusion from human adenocarcinoma, was purchased from the American Type Culture 
Collection (ATCC) (Rockville, MD). The cells were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) (pH 7.4) containing Phenol Red
+
 and supplemented with 
10% fetal bovine serum (FBS), 2 mM L-glutamine and 50 U penicillin-streptomycin 
(all reagents were supplied by Invitrogen; Auckland, New Zealand). Cells were 
cultured at 37°C in a humidified incubator with an atmosphere of 95% air and 5% 
carbon dioxide. For routine cultures the media were replenished every 2-3 days.  
 
For each experiment, the initial cultures were established in T-75 flasks 
(Nunc, Denmark). One millilitre of frozen stock containing approximately 1 x 10
6
 
cells/ml was seeded to 12 ml of culture medium. After about 6-8 h, the cells adhered to 
the surface of the flasks. At this time the culture medium was replaced with fresh 
medium. All cultures were examined regularly to confirm the healthy status of the cells 
and the absence of contamination. This was done under a phase contrast inverted 
microscope (Leitz Diavert, Germany). Growth morphology and characteristics were 
also carefully noted using a 10x Phaco objective and 12.5x eyepieces. Where 
appropriate, images were captured digitally (1280 x 960 pixels) on a hand-held Fujifilm 
camera (FinePix 4700 zoom, Japan).  
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Cells were subcultured when reaching 80% confluency to improve cell 
growth. The culture medium was removed and the cells were washed with 2 ml 
phosphate-buffered saline (PBS) to remove traces of serum. This solution contained 
0.13 M sodium chloride (NaCl), 14 mM di-Sodium hydrogen orthophosphate 
(Na2HPO4) and 3.5 mM sodium dihydrogen orthophosphate (NaH2PO4). The PBS was 
then discarded and the cells were treated for 2 min with 1 ml 0.25% (w/v) trypsin with 
0.53 mM ethylenediaminetetra-acetic
 
acid (EDTA) [Invitrogen; Auckland, New 
Zealand] to dissociate cells in the monolayer, and to detach the cells from the flask. 
Subsequently, 5 ml culture medium was added to the flask to re-suspend the cells. One 
millilitre aliquot of cell suspension was used to re-seed each T-75 flask. When cells 
were harvested for long term storage, the cells were resuspended in 10% dimethyl 
sulfoxide (DMSO) (Invitrogen; Auckland, New Zealand) containing DMEM and stored 
at -80
o
C. 
 
 
2.2.2.  Single cell clone isolation 
 
After subculturing, isolation of single cell clones was carried out 
according to the method of Freshney (2000). Conditioned medium was prepared to 
improve the plating efficiency of the cells. Firstly, the medium was harvested from 
cells of the late log phase. The medium was centrifuged for 5 min at room temperature 
and then the supernatant was diluted with 1 volume of fresh growth medium and stored 
at 4
o
C before use (Fig. 2.1).  
 
For single cell isolation (Fig. 2.2), a cell culture was trypsinised and the 
number of cells/ml was determined. To obtain a single cell for clone establishment, the 
culture was diluted serially to a final density of 3 cells/ml. One hundred µl of the 
diluted cell solution was then dispensed into each well in 96-well plates (Nunclon 
multidishes, Denmark). The plates were incubated until colonies formed. The clonal 
origin of the colony during its formation was confirmed by regular microscopic 
observation. When each single colony grew big enough to cover half of the area of the 
wells in the 96-well plates, they were treated with trypsin and transferred into a T-25 
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flask with 5 ml of conditioned. The cells were then subcultured as usual until they 
reached 80% confluency in the T-25 flask. 
 
 
 
 
 
Supernatant was collected from 80% confluence monolayer cell culture. 
 
  
 
Centrifuged at 3000 rpm for 10-15 min at room temperature. The pellet was discarded. 
 
                                                                          
 
The supernatant was replenished with the same volume of fresh growth medium. 
 
                                                                       
 
 
 
Figure 2.1. Preparation of conditioned medium. Collecting conditioned medium for single 
cell clone culture. 
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Exponentially grown MCF-7 cells were trypsinised. 
 
 
 
 
 
Cell number was counted. The cell concentration was diluted with conditioned medium 
to < 3 cells/ml.  
 
 
 
0.2 ml of the cell solution was seeded into each well of 96 well plates (about 0.7 
cells/well). 
 
 
 
 
 
Single colonies were noted. Wells with more than one colony were disregarded. 
 
 
           B5                 B12                D4                  D9                  E1                  E8    
 
 
 
 
Figure 2.2. Dilution cloning method. Single cell clones were isolated from MCF-7 cells by 
dilution cloning. 
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2.2.3.  Growth rate and doubling time 
 
To determine growth rates, cells from each clone were seeded in 24-well 
plates (Nunclon multidishes, Denmark) at cell concentrations of 1 x 10
4
 cells/ml/well. 
Cell morphology and growth characteristics were carefully noted under a phase contrast 
inverted microscope (Leitz Diavert, Germany). Cell counts were taken from three wells 
at time points. Cell growth rates were monitored over a range of time intervals until 
they reached the plateau phase, which was determined by at least three countings taken 
at three different time points that showed no increase in cell concentration. The culture 
media were changed every 2-3 days. The number of viable cells, as determined by 
trypan blue (Invitrogen; Auckland, New Zealand) exclusion, was counted daily using a 
hemocytometer and a Zeiss compound light microscope (Germany) at 125 x 
magnification. Mean values and standard deviations (SD) of the cell numbers were 
calculated. A semi-log growth curve was plotted and the lag time, population-doubling 
time (PDT), and plateau density were determined from the graph as described by 
Freshney (2000). The growth rates for all the clones were determined by separate 
growth experiments. 
 
 
2.2.4.  DNA extraction 
 
To detect variation at genomic level, DNA extraction was carried out as 
described by Cao et al. (2003). DNA was isolated from exponentially growing cells of 
the three clones (B12, D4 and D9) showing the most variability in growth rate. DNA 
was extracted using a buffer containing 0.1 M Tris-HCl, pH 8, 20 mM EDTA, 1% 
sodium dodecyl sulphate (SDS) (Sigma-Aldrich; St. Louis, MO), 100 µg/ml proteinase K 
(Roche; Mannheim, Germany) and 10 mM 1,4-dithiothreitol (DTT) (Boehringer 
Mannheim; Mannheim, Germany) at 37
o
C overnight. After overnight digestion, an equal 
volume of phenol and chloroform-isoamyl alcohol (25:24:1) was added to the digest 
and mixed well. DNA was then isolated by centrifugation at 10,000 x g for 10 min in 
an Eppendorf centrifuge (model 5417R) (Germany). The aqueous phase containing 
DNA was extracted with chloroform to remove residue phenol, followed by 
centrifugation as before. The purified DNA was precipitated out using 0.3 M sodium 
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acetate and ice cold 100% ethanol. Finally, purified DNA was solubilised in TE buffer 
(10 mM Tris-HCl, 1 mM EDTA, pH 8) and stored at 4
o
C.  
 
Quantitation of DNA was determined by a UV spectrophotometer 
(Ultraspec II 4050, LKB Biochrom Ltd; England). Absorbance wavelength was set at 
260 nm and 280 nm. The A260:A280 ratio was calculated to determine the purity of  
DNA. An A260:A280 ratio of 1.8 is indicative of highly purified DNA. The DNA 
concentration was calculated using the Beer-Lambert law, where an A260 reading of 1.0 
optical density (OD) unit is equivalent to 50 µg/ml double-stranded DNA (Sambrook et 
al., 1989).  
 
 
Equation for calculating the DNA yield of the samples: 
DNA  concentration    =    A260   x   50  µg/ml   x   dilution  factor 
 
 
The DNA was analysed by electrophoresis of 5 µl from each sample on 
a 1% agarose gel using 1x Tris-borate-EDTA (TBE) (0.9 M Tris base, 0.9 M boric acid, 
12.5 mM EDTA, pH 8) buffer at 5V/cm. After electrophoresis, the gels were stained 
with ethidium bromide (0.5 µg/ml) and visualised on a UV transilluminator (UltraLum 
Sci Tech, New Zealand) at 300 nm wavelength. Molecular size marker was a mixture 
of Lambda DNA (λDNA) fragments digested with Hind III and Eco RI (λHE) 
[Invitrogen; Auckland, New Zealand] (see Appendix 3). 
 
 
2.2.5.  Polymerase chain reaction (PCR) 
 
The entire mitochondrial genome was PCR amplified for clones B12, 
D4 and D9. These three clones showed distinctly different growth rates. Thirteen pairs 
of overlapping primer sets were designed to amplify the entire 16 569 bp mitochondrial 
genome (Table 2.1). Primers were based on the published human mitochondrial 
sequence from the Entrez database (accession number NC_001807) obtained from the 
National Centre for Biotechnology information (NCBI; http://www.ncbi.nlm.nih.gov.).  
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Table 2.1. Primer pairs used for the PCR amplification of mtDNA. 
 
Pair Primers 
Nucleotide 
positions 
Sequence 
( 5’  3’ ) 
Product 
size (bp) 
Ta 
o
C 
12S        F 628-647 ggctcacatcaccccataaa 
A 
16S        R 2646-2627 tcgtggagccattcatacag 
2019 58 
16S       F1 2335-2354 gcataagcctgcgtcagatc 
B 
ND1      R 4370-4351 ttttggattctcagggatgg 
2036 59 
ND1     F3 3930-3949 tctcaggcttcaacatcgaa 
C 
ND2      R 5566-5546 tgcaacttactgagggctttg 
1637 58 
ND2     F3 5199-5218 aattccatccaccctcctct 
D 
COI      IR 6758-6738 aaccctaggaagccaattgat 
1560 59 
COI      2F 6611-6630 gatttttcggtcaccctgaa 
E 
COI      2R 7600-7581 gctgcatgtgccattaagat 
990 59 
T7  COII    IF 7495-7514 T7-catggcctccatgacttttt 
F 
T3  COII    IR 8485-8466 T3-tttggtgagggaggtaggtg 
991 59 
T7 ATPase6 F 8466-8485 T7- cacctacctccctcaccaaa 
G 
T3 ATPase6 R 9336-9317 T3-gaggagcgttatggagtgga 
871 55 
T7 COIII  IF 9184-9203 T7- cctctacctgcacgacaaca 
H 
T3 COIII  IR 10176-10158 T3-gcactcgtaaggggtggat 
993 59 
HMTL 1012   F 10124-10143 tttgactaccacaactcaac 
I 
HMTH12211 R 12211-12191 tctcggtaaataaggggtcgt 
2088 58 
ND5A      F 12066-12085 ctcatgttcatacacctatc 
J 
ND5D      R 13512-13492 ttggagtagaaacctgtgag 
1447 58 
ND5C      F 12890-12909 gccttagcatgatttatcct 
K 
ND5B      R 14151-14132 ggttatgtgattaggagtag 
1262 57 
ND6         F 14050-14069 ctccacctccatcatcacct 
L 
Cyt B        R 16006-15986 agaatcttagctttgggtgct 
1957 59 
D-Loop     F 15882-15901 tgggcctgtccttgtagtat 
M 
D-Loop     R 710-692 ggggatgcttgcatgtgta 
1400 59 
 
 
F – forward primer, R – reverse primer, T7 – taatacgactcactataggg, T3 – attaaccctcactaaaggga,  
Ta – annealing temperature. 
 
 
The primers were designed using a web based program, Primer3 
(http://www.path.com.ac.uk/cgi.bin/primer3.cgi). For each primer pair design, the 
primer length, melting temperature (Tm), GC content and length of PCR product were 
taken into consideration.  The compatibility of the primers was then checked to ensure 
that no primer dimers were formed using the FastPCR software (Kalendar 2004, 
http://www.biocenter.helsinki.fi/bi/programs/fastpcr.htm). The oligonucleotide primers 
were chemically synthesised by Invitrogen (Auckland, New Zealand). The generated 
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fragments were 800-2100 bp in length. The amplified fragments had at least 80 bp 
overlap at each end.  
 
PCR amplification was carried out according to the manufacturer’s 
instructions (Roche; Mannheim, Germany). Each 50 µl PCR reaction contained 1x 
PCR buffer containing 15 mM Mg
2+
 (Roche; Mannheim, Germany), 0.8 µM primers 
(Invitrogen; Auckland, New Zealand), 0.2 mM deoxyribonucleoside triphosphate 
(dNTPs) [Progen Biosciences; Queensland, Australia], 1.25 U Taq polymerase (Roche; 
Mannheim, Germany) and 100 ng DNA template. For each set of PCR, a negative 
control (without DNA template) and a positive control of a known DNA sequence were 
run in parallel to ensure that the PCR products were not due to contaminations in the 
PCR reagents, and that the PCR was amplifying specific DNA sequences. The cycle 
parameters were as followed: 94
o
C for 2 min (initial denaturation); 30 cycles of 94
o
C 
for 30 s (denaturation), 55
o
C - 59
o
C for 45 s (annealing) and 72
o
C for 2 min (extension). 
The final extension proceeded for 7 min. The amplification was done on a PTC-225 
Peltier Thermal Cycler (MJ Research, Germany). The size of the PCR fragments was 
estimated by comparison with λHE molecular markers after electrophoresis. The PCR 
products were stored at 4
o
C until use. 
 
 
2.2.6.  Purification of PCR products 
 
All PCR-amplified products were subsequently purified for sequencing 
using a GFX purification kit (Amersham Pharmacia Biotech; Freiburg, Germany). PCR 
products were also eluted from agarose gels using Matrix Gel Extraction Protocol (Life 
Technologies; Grand Island, NY). The bands of interest were excised with a sterile 
surgical scalpel and melted at 60
o
C. These gel slices were then processed to obtain 
purified PCR products. The purified PCR products were stored in TE8 at 4
o
C. 
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2.2.7.  mtDNA sequencing and analysis 
 
The purified PCR products were sequenced directly using an ABI 
PRISM BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems; Foster 
City, CA) on an ABI 377 automated DNA sequencer (Perkin-Elmer; Foster City, CA). 
Additional mtDNA primers for sequencing long fragments of PCR products were also 
designed (Table 2.2). The sequencing reactions contained 50 ng of purified PCR 
product, 0.5 µl BigDye Terminator (BDT) reaction mix, 1.75 µl 5x sequencing buffer 
(containing 350 mM Tris-HCl, pH 9.0 and 2.5 mM MgCl2), 3.2 pmol primer and 
ddH2O to a total volume of 10 µl. Thermocycling conditions were as followed: 96
o
C x 
10 s, 50
o
C x 10 s, 60
o
C x 1 min (25 cycles). Unincorporated primers and dye 
terminators were removed using DNA grade Sephadex-G50 (Amersham; Richmond, 
CA) gel filtration prior to sequencing.  
 
 
Table 2.2. Additional mtDNA primers used in ABI sequencing. 
 
Primers Nucleotide positions Sequence ( 5’  3’ ) 
16S   F 1591-1611 cacttggacgaaccagagtgt 
12S   R 1705-1686 gtaaggtggagtgggtttgg 
ND1  F 3246-3265 cccggtaatcgcataaaact 
16S  R1 3366-3347 aggaatgccattgcgattag 
ND2  F 4383-4402 cctatcacaccccatcctaa 
ND2  R3 5309-5290 gtggggatgatgaggctatt 
HMTL 9798  F 9798-9817 ttttgtagccacaggcttcc 
HMTL 10688  F 10688-10708 tgggcctagccctactagtct 
HMTH 10851  R 10851-10832 tgtgggtggttgtgttgatt 
HMTH 1246  R 12461-12443 gatgcgacaatggattttac 
Cyt B  F 14621-14640 ccccacaaaccccattacta 
ND6   R 14755-14736 ggggtcattggtgttcttgt 
  
F – forward primer, R – reverse primer 
 
 
All fragments were sequenced from both the forward and backward 
direction to assure
 
sequence reading precision. The sequencing reactions were 
performed at least two times for confirmation. Sequences were edited to remove 
ambiguous portions from the 5’ and 3’ ends. The results of mtDNA sequence analysis 
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were then compared among clones with reference to the latest revised National Center 
for Biotechnology Information (NCBI) sequence viewer ( accession number 
NC_001807, February 2006 version) using a DNA mutation analysis software 
(SEQUENCHER 4.5, USA). 
 
 
2.2.8.  Sensitivity of heteroplasmy detection 
 
To establish the limits of detection of mtDNA heteroplasmy by 
sequencing, heteroplasmic sensitivity mixing experiments were carried out.  DNA 
sample from a homoplasmic individual (D4) was mixed with the DNA sample from a 
heteroplasmic individual (B12) with a well-characterised heteroplasmic A2520T 
mutation within the 16S rRNA gene. The DNA mixture ratios were 50:50, 80:20, 90:10 
and 95:5. The levels of heteroplasmy were resolved by calculating the total areas under 
the two overlapping peaks and expressed each as a percentage area of the total area 
(Harris et al., 2006). 
 
 
2.2.9.  Mutational analysis 
 
(i)    RNA secondary structure prediction 
 
Secondary structures for the mutated human mitochondrial 16S rRNAs 
were generated using the RNAfold software from the Vienna RNA package (Hofacker 
2003; http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi). RNAfold predicts RNA 
secondary structure based on free energy minimisation and pair probabilities. 
 
 
(ii)    Amino acid sequence analysis 
 
Predictions of protein structure and function were performed using the 
tools found on the internet. Primary structural analysis to determine the hydropathicity 
Chapter 2 MATERIALS & METHODS 
 
 
30 
and polarity was carried out using the ProtScale software 
(http://www.expasy.org/tools/protscale.html), which implements the scale of Kyte and 
Doolittle (1982), and Grantham (1974), respectively. Functional analysis including 
protein secondary structure and transmembrane regions were predicted using nnPredict 
(http://www.cmpharm.ucsf.edu/~nomi/nnpredict.html) and TMpred 
(http://www.ch.embnet.org/software/TMPRED_form.html), respectively.  
 
 
2.2.10.  Isolation of mitochondria 
 
Mitochondria were required to investigate the biogenetic activities in the 
cells of the three clones. Isolation of intact mitochondria was based on a modification 
of the method described by Madsen et al. (1996), where mitochondria were prepared by 
differential centrifugation. The entire process was performed at 4
o
C. All glassware 
were first rinsed in sucrose-Hepes-EGTA (0.25 M sucrose, 10 mM Hepes-NaOH (pH 
7.2), 2 mM EGTA) (SHE) buffer before use.  
 
Exponentially growing cells of the three single clones (B12, D4 and D9) 
were collected by trypsinisation and re-suspensed in 50 µl PBS. The cell suspension 
was then incubated in 500 µl of ice-cold SHE buffer and treated with 0.01% digitonin 
(w/v) to remove the outer mitochondrial membrane. Fragments of inner membrane 
were obtained by osmotic rupture of the mitochondria, and enzymes, which were 
embedded in the inner mitochondrial membrane, were exposed. After 10 min of 
incubation on ice (4
o
C), the cell suspension was homogenised using a glass-glass 
homogeniser by making at least 100 strokes to help breaking open the cell membrane 
completely.  
 
The homogenate was then centrifuged at 700 x g for 10 min to pellet 
unbroken cells, nuclei and debris. The supernatant, which contained the mitochondria, 
was transferred to a new tube and the pellet was discarded. Mitochondria were 
sedimented from the supernatant by centrifugation at 12,000 x g for 15 min at 4
o
C. The 
mitochondrial pellet had a brown core covered by a lighter fluffy layer. This pellet was 
carefully washed with 500 µl SHE buffer, followed by centrifugation at 700 x g for 5 
Chapter 2 MATERIALS & METHODS 
 
 
31 
min at 4
o
C.  Subsequently, the washed pellet was re-suspend in 100 µl of SHE buffer 
and stored at -20
o
C until used for enzyme assays. 
 
 
2.2.11.  Quantitation of mitochondria (Bradford assay) 
 
The mitochondrial protein concentration was determined according to 
the method of Bradford (1976) using dye reagent from Bio-Rad (Richmond, CA). The 
dye reagent consisted of Coomassie Blue G-250 which was dissolved in 95% ethanol 
and kept in the dark prior to the assay. The assay was carried out in triplicates; 
absorbance was determined at 595 nm using a UV-visible spectrophotometer 
(Shidmadzu UV-1601 PC, Japan). Protein concentrations were determined by colour 
changed (brown  blue) upon binding of protein to Coomassie Blue. 
 
Dye reagent was prepared by diluting 1 part of Bio-Rad dye reagent 
concentrate with 4 parts of ddH2O.  A range of protein standards (0-1500 µg/ml) were 
made up from a stock solution of 2 mg/ml bovine serum albumin (BSA) (AppliChem; 
Darmstadt, Germany). These protein standards were prepared in SHE buffer, the same 
buffer as the mitochondrial samples to be assayed. Five µl of standard and 200 µl dye 
were added and made up to 1 ml with ddH2O for each reading. The solution was mixed 
well and incubated at room temperature for 5 min before being assayed. A standard 
graph of absorbance against BSA concentration was plotted to provide a relative 
measurement of protein concentration. 
 
 
2.2.12. Enzyme assays 
 
To investigate whether a mutation in the mitochondrial genome 
correlated with any biochemical defect in the mitochondrial complex, enzymatic assays 
were carried out. Enzymatic measurements were performed in isolated mitochondria. 
All five oxidative phosphorylation (OXPHOS) enzymes were assayed using a UV-
visible spectrophotometer (Shidmadzu UV-1601 PC, Japan) equipped with a 
temperature-controlled (Thermoltaake DC10, Germany) cuvette holder. Enzyme assays 
Chapter 2 MATERIALS & METHODS 
 
 
32 
were carried out in triplicates in a one ml reaction volume containing 25 µg/ml of 
mitochondria at 30
o
C. All enzyme activities were normalised with reference to the 
activity of the mitochondrial marker enzyme citrate synthase (CS) in each sample to 
discriminate very partial specific enzymatic OXPHOS defects (Barrientos 2002). All 
chemicals used for enzyme assays were obtained from Sigma-Aldrich (St. Louis, MO).  
 
 
(i)    Citrate synthase assay 
 
CS activity was measured according to the method of Shepherd and 
Garland (1969). The reaction mixture contained 100 mM Tris-HCl (pH 8.0), 100 mM 
acetyl coenzyme A, 200 mM [5,5’-dithio-bis-(2-nitrobenzoic) acid] (DTNB), 0.1% (v/v) 
Triton X-100 . The assay was initiated by the addition of 200 µM oxaloacetate (OAA) 
after mitochondria were added for 3 min. CS coupled Coenzyme A to DTNB.  The 
formation of 5-thio-2-nitrobenzoate was monitored at 412 nm. Control assays in which 
oxaloacetate was omitted, were also performed to quantify any transfer of the 
sulfhydryl groups to DTNB other than that caused by CS activity.  
 
  The millimolar extinction coefficient of DTNB is 13.6. 
 
 
(ii)    NADH-Ubiquinone oxidoreductase (Complex I) assay 
 
The activity of rotenone-sensitive NADH:ubiquinone oxidoreductase 
was measured in 25 mM potassium phosphate buffer (pH 7.4) containing 5 mM 
magnesium chloride (MgCl2), 2 mM potassium cyanide (KCN), 2.5 mg/ml albumin, 2 
µg/ml antimycin A, 65 µM ubiquinone, 130 µM nicotinamide adenine dinucleotide 
(NADH) and the mitochondria sample at 340 nm according to Birch-Machin et al. 
(1994). Ubiquinone (CoQ1) acted as an electron acceptor and was reduced to ubiquinol, 
showing a decrease in NADH absorbance. After 5 min, 2 µg/ml rotenone was added 
and the reaction was noted for a further 5 min. The rotenone-sensitive rate was then 
calculated by subtracting the rotenone-inhibited rates from the CoQ1-stimulated rate.  
 
  The millimolar extinction coefficient of NADH is 6.81. 
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(iii)  Succinate dehydrogenase (Complex II) assay 
 
  Mitochondrial complex II activity was measured based on a 
modification of the method described by Ackrell et al. (1978). This assay measured the 
reduction of ferricyanide at 420 nm. The assay was conducted in 100 mM potassium 
phosphate buffer (pH 7.4), 20 mM sodium succinate, 1 mg/ml BSA and mitochondria 
sample. This mixture was mixed well and placed in a 30
o
C water bath for 10 min. After 
10 min of incubation, 100 µM potassium ferricyanide (K3[Fe(CN)6]) was added and the 
reaction was registered for a further 3 min.  
 
  The millimolar extinction coefficient of ferricyanide is 1.0. 
 
 
(iv)   Ubiquinol -cytochrome c oxidoreductase (Complex III) assay 
 
Mitochondrial complex III activity was measured according to the 
method of Birch-Machin et al. (1994). The reaction mixture contained 25 mM 
potassium phosphate buffer (pH 7.4), 5 mM MgCl2, 2 mM KCN, 2.5 mg/ml BSA, 2 
µg/ml rotenone, 15 µM cytochrome c (III) and the mitochondrial sample. The reaction 
was initiated by the addition of 35 µM ubiquinol which acted as a substrate. This 
enzyme donated electrons from ubiquinol to cytochrome c (III), and the reduction of 
cytochrome c was monitored by an increase in absorbance at a wavelength of 550 nm.  
 
  The millimolar extinction coefficient of cytochrome c (II) is 19.0. 
 
  The preparation of reduced ubiquinone (ubiquinol) was performed as 
described by Hatefi (1978). In a Falcon tube (BD Biosciences, Australia), 10-50 mg 
ubiquinone were dissolved in 3 ml of absolute ethanol, acidified to pH 2 with 6 M HCl. 
An equal volume of water was added. The quinine was then reduced with excess 
sodium borohydride (NaBH4). The lid was closed after 2 ml of cyclohexane was added 
and the contents were vortexed briefly. After the cyclohexane was separated from the 
aqueous layer, it was extracted and evaporated to dryness under vacuum until reduced 
ubiquinone (ubiquinol) was collected in the tube as pale yellow oil. Absolute ethanol 
was added, followed by a small volume of 6 M HCl to retard oxidation. This solution 
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was then kept at -80
o
C until use. Conversion to the oxidised quinone could be easily 
detected by the reappearance of the yellow colour of ubiquinone. 
 
 
(v)    Cytochrome C Oxidase (Complex IV) assay 
 
  The activity of complex IV was measured using a modified method of 
Birch-Machin et al. (1994). This assay measured the oxidation of cytochrome c (II) that 
led to a decrease in absorbance at 550 nm. The concentration of cytochrome c (II) was 
determined before each batch of assays. The assays were performed in a reaction 
mixture containing 10 mM potassium phosphate buffer (pH 7.4) and 15 µM 
cytochrome c (II). The reaction was initiated by the addition of mitochondrial sample 
and measured for 5 min. 100 mM ferricyanide was then added to fully oxidised 
cytochrome c (II).  
 
  The millimolar extinction coefficient of cytochrome c (III) is 19.1. 
 
  Cytochrome c (III) was dissolved in 10 mM potassium phosphate buffer 
(pH 7.4). The solution was reduced to cytochrome c (II) with a few crystals of sodium 
L-ascorbate and separated by Sephadex-G25 chromatography. A colour change was 
observed upon reduction of the solution. Reduced cytochrome c concentration was then 
determined using reduced-oxidised different extinction coefficient of ∆ε550-542 = 19.6 
mM
-1
cm
-1
 prior to the assay. This was done by using a UV-visible spectrophotometer 
(Shimadzu UV-1601 PC, Japan) at wavelengths of 542 nm and 550 nm. 
 
 
  Equation for determining cytochrome c concentration: 
 
 
[ ] Dilution
oxidisedreduced
×
 ∆
+
=
−542−550 )(
(oxidised)550(oxidised)542(reduced) 542(reduced) 550
 A-  A  A - A
    mM  c Cytochrome
ε
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(vi)    ATP synthase (Complex V) assay 
 
  The enzymatic activity of ATPase in the mitochondrial inner membrane 
was monitored at 340 nm, according to the method of Pullman et al. (1960). The 
millimolar extinction coefficient is 6.22. The reaction buffer contained 100 mM Tris 
buffer (pH 8.0), 200 µM NADH, 1 mM phosphoenol pyruvate (PEP) (pH 6.0), 2 U/ml 
L-lactic dehydrogenase (LDH), 4 U/ml pyruvate kinase (PK), 2.5 mM MgATP (pH 7.0) 
and observed for 3 min until the NADH level had stabilised. Mitochondrial samples 
were then added and the decrease in absorbance resulting from the consumption of 
hydrolysed ATP was measured. After 5 min, 0.1 mM oligomycin (ATP inhibitor) was 
added to measure the oligomycin insensitive rate.  
 
 
2.2.13. Effect of extracellular adenosine 5’-triphosphate (ATP) on 
  cell proliferation 
 
  Cell proliferation assay was carried out to evaluate the effect of 
extracellular ATP on cells growth. Exponentially growing B12 cells and D4 cells were 
seeded in 24-well plates (Nunclon multidishes, Denmark) at 1 x 10
4
 cells/ml/well and 
cultured as described previously. The cells were left to attach to the flask for 24 h. 
After 24 h, B12 cells (slowest growth) were then treated with increasing ATP (Sigma-
Aldrich; St. Louis, MO) concentrations (0 µM, 50 µM, 100 µM and 1 mM). D4, which 
was the fastest growing clone, was cultured without exogenous ATP as a reference for 
comparison. The culture medium was replaced daily by fresh medium containing the 
appropriate ATP concentrations to alleviate the concern about the degradation of ATP 
during incubation. Growth morphology and characteristics were carefully observed 
under a phase contrast inverted microscope (Leitz Diavert, Germany). The cell numbers 
from three wells were determined daily by trypan blue staining as described before. 
The growth rates were determined from triplicate experiments. Growth curves for each 
treatment were plotted.  
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2.2.14. RNA extraction from cell cultures 
 
  Total RNA was extracted from exponentially growing cells using TRI 
Reagent (Molecular Research Center, Inc, Cincinnati, OH) which contained phenol and 
guanidine thiocyanate in a procedure based on the method of Chomczynski and Sacchi 
(1987). Cells were first rinsed with PBS and subsequently lysed in TRI Reagent (1 ml 
per 5-10 x 10
6
 cells) for 5 min at room temperature. RNA was separated from DNA and 
protein by extraction with chloroform. RNA was then precipitated with ½ volume of 
isopropanol and spun at 12,000 x g for 15 min at 4
o
C. The RNA pellet was then washed 
with 75% ethanol, centrifuged at 7,500 x g for 5 min and vacuum dried for 5 min. RNA 
was then solubilised in 50-80 µl diethyl pyrocarbonate (DEPC)-treated water (Sigma-
Aldrich; St. Louis, MO). The isolated RNA was subjected to RNase-free DNase I 
(Fermentas; Ontario, Canada) digestion for 30 min at 37
o
C in the presence of Mg
2+
. 
The reaction was arrested by 1 µl of 25 mM EDTA and incubated at 65
o
C for 10 min. 
PCR was performed to check for potential DNA contamination by using purified RNA 
samples directly as the templates. Samples containing residual genomic DNA were 
redigested with RNase-free DNase I and assayed again for DNA contamination. The 
DNA-free RNA was then stored in 100% ethanol at -80
o
C until use. 
 
 
2.2.15. Quantitation and visualisation of RNA 
 
  The concentration of RNA was determined by using a fluorescence-
based Quant-iT™ RNA Assay kit (Molecular Probes; Oregon, US) on a multiplex 
quantitative PCR system (MxPro-Mx3005P, Stratagene, US). The optical path of the 
sulfonated indocyanine dye Cy3 was assigned at excitation wavelength 635 nm and 
emission wavelength 665 nm. The quantity of RNA was determined by comparison 
with an E.coli rRNA standard curve (mass of RNA in ng vs. fluorescence). The purity 
of the isolated total RNA was assessed by UV spectrophotometry (Ultraspec II 4050, 
LKB Biochrom Ltd; England) by referring to absorbance ratios A260:A280. As RNA 
A260:A280 ratio is dependent on both pH and ionic strength (Wilfinger et al., 1997), TE 
(pH 8) was used as a dilutant and a blank to assure accurate readings. The integrity of 
the total RNA was analysed by electrophoresis on a denatured 1% agarose-
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formaldehyde gel using 1 x 3-(N-morpholino)-propanesulfonic acid (MOPS) buffer 
(Sigma-Aldrich; St. Louis, MO). The integrity of the total RNA was judged by the 
integrity of 28S and 18S rRNA. 
 
 
2.2.16. Reverse transcription of RNA 
 
  Reverse transcription PCR analysis of mt-cDNA was carried out to 
investigate the expression of mutated 16S rRNA, ND1, ND4, ND6 and COX III genes 
involved in OXPHOS.  
 
 
(i)  cDNA synthesis 
 
  Two µg of DNase I-digested RNA template from each clone was copied 
into complementary DNA (cDNA) using GeneAmp Gold RNA PCR Core Kit (PE 
Biosystems; Foster City, CA). The total RNA was first incubated with 50 ng of 
hexamers and 1 mM of dNTP mix for 5 min at 65
o
C and chilled on ice for another 5 
min. A reaction mixture (40 units of RNase inhibitor, 4 µl of 5x RT buffer, 4 µl of 25 
mM MgCl2 and 2 µl of 0.1 M DTT) was added to the RNA/hexamers mixture 
mentioned above and incubated at 25
o
C for 2 min. Briefly, 50 units of reverse 
transcriptase (RT) were added to each sample and incubated at 25
o
C for 10 min 
followed by 42
o
C for 50 min. This reaction was terminated by heating at 70
o
C for 15 
min and subsequently chilled on ice. Two units of RNase H was added to the 
synthesized cDNA and incubated for 20 min at 37
o
C to digest any residual RNA. The 
cDNA was stored at -20
o
C before proceeding to amplification of the target DNA. 
 
  To confirm the efficiency of the first-strand synthesis reaction, a positive 
control using 50 ng in vitro transcribed RNA from the chloramphenicol 
acetyltransferase (CAT) gene (Invitrogen; Auckland, New Zealand) was included. A 
negative control identical to the test assay but omitting the RT reaction was included 
for each gene tested to test for the presence of genomic DNA contamination.  
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(ii)  Comparative RT-PCR 
 
  PCR was performed as mentioned before. Five genes were amplified: 
16S rRNA, ND1, ND4, ND6 and COX III. Each primer pair (Table 2.3) annealed 
optimally at 59
o
C, thereby permitting simultaneous amplification of the reactions 
(multiplex). The final reaction volume was 50 µl. Negative controls (using water 
instead of cDNA template) were included in each PCR run.  
 
 
Table 2.3.  mtDNA primers used in RT-PCR. 
 
Primers 
Nucleotide 
positions 
Sequence 
( 5’  3’ ) 
Product size 
(bp) 
16S       F1 2335-2354 gcataagcctgcgtcagatc 
16S       R1 3366-3347 aggaatgccattgcgattag 
1032 
ND1      F 3246-3265 cccggtaatcgcataaaact 
ND1      R 4370-4351 ttttggattctcagggatgg 
1125 
HMTL 1012   F 10124-10143 tttgactaccacaactcaac 
HMTH12211 R 12211-12191 tctcggtaaataaggggtcgt 
2088 
ND6      F 14050-14069 ctccacctccatcatcacct 
ND6      R 14755-14736 ggggtcattggtgttcttgt 
706 
T7 COIII  IF 9184-9203 T7 - cctctacctgcacgacaaca 
T3 COIII  IR 10176-10158 T3 - gcactcgtaaggggtggat 
993 
 
F – forward primer, R – reverse primer, T7 – taatacgactcactataggg, T3 – attaaccctcactaaaggga,  
 
 
  The internal reference was the amplification of 18S rRNA (Roche; 
Branchburg, NJ). The band intensity of 18S rRNA after electrophoresis and ethidium 
bromide staining was used as an internal reference. This provided an estimation of the 
relative amount of target RNA in the cell samples. Visualisation of gels was carried out 
on CHEMI GENIUS Bio Imaging System using GeneSnap version 6.05 (Syngene; 
England). Intensities of the PCR product bands were quantified by using GeneTools 
version 3.06 (SynGene; England). 
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2.2.17. Statistical analysis 
 
  All statistical analyses were performed using parametric methods. Data 
were expressed as means ± SD calculated from the number (n) of replicas. One-way 
analysis of variance (ANOVA) was used for statistical evaluation. Where appropriate, 
post hoc comparisons using the Tukey’s Honestly Significant Different (HSD) test 
were carried out to determine which pairs of groups were statistically different.  A p-
value of < 0.05 was accepted as the level of statistical significance. Analyses were 
performed using GraphPad Prism Version 4.00 for Windows (GraphPad software, 
California; www.graphpad.com) or Microsoft
®
 Windows
®
 Excel 2003 software. 
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3.1.   Morphology and characteristics of the clone cells 
 
  Six clones (B5, B12, D4, D9, E1 and E8) each derived from a single cell 
were isolated from MCF-7 stock. The images of cells growing in the centre of the 
culture flasks were captured digitally using a hand-held camera (Fig. 3.1A-F). These 
images represented cells after subculturing from the initial established single cell 
colonies. All cells showed a typical epithelial morphology and were regular in shape, 
with a clearly defined edge. As the cell density increased, most cells were arranged in 
clusters, and these clusters displayed a cobblestone appearance as they reached 
confluency. Unlike cells of other clones that tended to clump together in patches, clone 
B12 was more scattered (Fig. 3.1B). B12 cells also had poorer adhesion and required 
longer time to attach to the culture vessel after seeding.  
 
  At early confluency (3-day old), clones D4 and D9 had protruding 
structures growing from the membrane but disappeared when the cell density increased. 
However, the protruding structures were seen throughout the whole culture time 
particularly in E8 cells (Fig. 3.1F). E8 cells also had a granular look around the nucleus 
but cytoplasmic vacuolation was absent. 
 
 
3.2.   Growth curve and doubling time 
 
  Figure 3.2 shows cell counts plotted on a log scale against time. Cell 
number was calculated per well, per ml of culture medium (left y-axis), and per cm
2
 of 
available growth surface in the well (right y-axis). The six single cell clones showed a 
characteristic growth pattern consisting of a lag phase, an exponential phase (log phase) 
and a stationary phase (plateau phase). In preliminary growth studies, the six clones 
revealed different growth rates (Fig. 3.2).  
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B5 – newly subcultured monolayer 
 
B12 – contact inhibited and 
               rounding up of the cells 
  
D4 – clusters at 60% confluency D9 – discrete clusters 
  
E1 – cells clumped together 
 
E8 – protruding structure at 60% 
confluency 
 
Figure 3.1. Growth morphology and characteristics of MCF-7 clones in culture. Six 
single cell clones of MCF-7 cells, cloned by dilution cloning. Epithelial morphology. Phase 
contrast. Scale bar 50 µm. A and B were taken at Day 1. D and E were taken at Day 2. C and F 
were taken at Day 4. 
A B
A 
D
A 
C
A 
F
A 
E
A 
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  A one-way between-clones analysis of variance (ANOVA) was 
conducted to determine the significance of the observed variation in growth rates of the 
six clones. The mean doubling times of the clones are shown in Table 3.1. There was a 
statistically significant difference in growth rates among the different clones [F(5,12) = 
29.89, p < 0.0001]. Post hoc comparisons using the Tukey’s Honestly Significant 
Different (HSD) test and means grouping indicated that the mean doubling time of B12, 
D4 and D9 were significantly different from B5, E1 and E8 (see Appendix 2). 
Statistical significances were assessed by one-way analysis of variance (ANOVA). A 
summary of the p-values between clones is shown in Table 3.2. 
 
 
Table 3.1. Doubling time of six cell clones. Values of the clones are shown as mean ± SD. 
 
Cell clone Mean doubling time (h) 
B5 26.4 ± 0.5 
B12 43.2 ± 4.8 
D4 25.7 ± 1.9 
D9 33.6 ± 0 
E1 26.9 ± 0.5 
E8 28.8 ± 0 
MCF-7 29 * 
 
* Doubling time supplied by the American Type Culture Collection (ATCC). 
 
 
Table 3.2. Tukey HSD test of six single cell clones. Pairwise between-group comparisons 
showing p-values between clones. Statistical significance was set at p-value < 0.05. NS, not 
significant. 
 
 B12 D4 D9 E1 E8 
B5 < 0.001 NS < 0.05 NS NS 
B12  < 0.001 < 0.01 < 0.001 < 0.001 
D4   < 0.01 NS NS 
D9    < 0.05 NS 
E1     NS 
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3.3.   DNA extraction 
 
  In order to understand the role of mitochondrial function on the different 
growth rates observed in clones B12, D4 and D9, DNA was extracted from the 
exponentially growing cells of these three clones. Table 3.3 shows the purity and 
concentration of DNA obtained from the three clones. The A260:A280 ratios of the three 
clones were greater than 1.8, indicating highly purified DNA. Figure 3.3 shows DNA 
analysed by electrophoresis. Subsequently, these DNA were used for PCR 
amplification of the entire mitochondrial genome and sequence analysis.  
 
 
Table 3.3. The purity and concentration of DNA from three clones. 
 
Clones A260:A280 ratio Stock DNA concentration 
B12 1.905 200 µg/ml 
D4 1.853 315 µg/ml 
D9 1.912 325 µg/ml 
 
 
 
 
Figure 3.3. Analytical gel showing DNA extracted from the three clones of MCF-7 cells. 
Five microliters of DNA were separated by electrophoresis on 1% agarose gel, stained with 
ethidium bromide, and observed under ultraviolet illumination. Lane λHE: molecular weight 
marker; lanes B12, D4 and D9: DNA from single clones represented according to clone name. 
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3.4.   PCR amplification and purification  
 
  Thirteen mitochondrial DNA fragments of the predicted sized were 
successfully amplified from each of the three clones using mtDNA specific primers 
(Table 2.1). The PCR products were size-fractionated on 1% agarose gels and each 
fragment was purified for later use as templates for sequencing. No visible PCR 
products were seen in the negative control (data not shown). Representative gels of the 
purified PCR products are depicted in Fig. 3.4-3.10. The purified PCR products were 
then stored at 4
o
C until use for sequencing. 
 
 
 
 
 
 
 
Figure 3.4. PCR amplification of mtDNA isolated from three single clones. 50 ng total 
DNA templates was amplified (50 µl PCR reaction) by primer pairs A and B (Table 2.1). 
The expected sizes of these products were 2019 bp and 2036 bp, respectively. Ten 
microlitres of PCR products were loaded per lane. Lane λHE: molecular weight marker; 
lanes B12, D4 and D9: DNA from single clones represented according to clone name.  
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Figure 3.5. PCR amplification of mtDNA isolated from three single clones. 50 ng total 
DNA templates was amplified (50 µl PCR reaction) by primer pairs C and D (Table 2.1). 
The expected sizes of these products were 1637 bp and 1560 bp, respectively. Ten 
microlitres of PCR products were loaded per lane. Lane λHE: molecular weight marker; 
lanes B12, D4 and D9: DNA from single clones represented according to clone name. 
 
 
 
 
Figure 3.6. PCR amplification of mtDNA isolated from three single clones. 50 ng total 
DNA templates was amplified (50 µl PCR reaction) by primer pairs E and F (Table 2.1). 
The expected sizes of these products were 990 bp and 991 bp, respectively. Ten microlitres 
of PCR products were loaded per lane. Lane λHE: molecular weight marker; lanes B12, D4 
and D9: DNA from single clones represented according to clone name.  
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Figure 3.7. PCR amplification of mtDNA isolated from three single clones. 50 ng total 
DNA templates was amplified (50 µl PCR reaction) by primer pairs G and H (Table 2.1). 
The expected sizes of these products were 871 bp and 993 bp, respectively. Ten microlitres 
of PCR products were loaded per lane. Lane λHE: molecular weight marker; lanes B12, D4 
and D9: DNA from single clones represented according to clone name.  
 
 
 
 
 
Figure 3.8. PCR amplification of mtDNA isolated from three single clones. 50 ng total 
DNA templates was amplified (50 µl PCR reaction) by primer pairs I and J (Table 2.1). 
The expected sizes of these products were 2088 bp and 1447 bp, respectively. Ten 
microlitres of PCR products were loaded per lane. Lane λHE: molecular weight marker; 
lanes B12, D4 and D9: DNA from single clones represented according to clone name.  
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Figure 3.9. PCR amplification of mtDNA isolated from three single clones. 50 ng total 
DNA templates was amplified (50 µl PCR reaction) by primer pairs K and L (Table 2.1). 
The expected sizes of these products were 1262 bp and 1957 bp, respectively. Ten 
microlitres of PCR products were loaded per lane. Lane λHE: molecular weight marker; 
lanes B12, D4 and D9: DNA from single clones represented according to clone name.  
 
 
 
 
 
Figure 3.10. PCR amplification of mtDNA isolated from three single clones. 50 ng 
total DNA templates was amplified (50 µl PCR reaction) by primer pair M (Table 2.1). The 
expected sizes of these products were 1400 bp. Ten microlitres of PCR products were 
loaded per lane. Lane λHE: molecular weight marker; lanes B12, D4 and D9: DNA from 
single clones represented according to clone name.  
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3.5.   mtDNA mutation analysis 
 
  Sequence analyses of the entire mitochondrial genome revealed 38 
mutations common to all three clones (Table 3.4) and seven clone-specific mutations 
(Table 3.5) found in the clones. The common mutations consisted of transition, 
transversion, deletion and insertion. All base substitutions were homoplasmic. Of the 
38 common mutations, 12 polymorphisms were in the hypervariable D loop region, 12 
polymorphisms in the ND gene, 6 polymorphisms in the COX gene, 3 polymorphisms 
in the 16S rRNA, 2 polymorphisms in the Cyt b, 1 polymorphism each in the ATPase 6, 
tRNA
Thr
 and
 
the intergenic region, respectively. These mutations were different from 
the revised NCBI reference sequence (accession number NC_001807, version February 
2006).  As shown in Fig. 3.11 – 3.15, of the seven clone-specific mutations, one of 
these mutations was in a homoplasmic state (in ND4) and six displayed heteroplasmies 
(three in 16S rRNA, one each in ND1, ND6 and COX III). The results were confirmed 
by repeated amplification and sequencing with alternative primers.  
 
  Clone B12 harboured five transversion mutations at nucleotides (nts) 
2480, 2513, 2520 (Fig. 3.11), 9527 (Fig. 3.12) and 14263 (Fig. 3.13). The mutations at 
2480, 2513 and 2520 were found to be located at the 16S rRNA of mtDNA. Every 
mutation was heteroplasmic as indicated by the presence of double peaks at respective 
positions. The C9527T mutation resulted in an alanine  serine substitution at amino 
acid position 107 (A107S) in the COX III subunit. The C14263G mutation caused an 
aspartic acid  histidine substitution at amino acid position 138 (D138H) of the ND6 
subunit. A heteroplasmic mutation was also found in clone D9, displaying both A and 
G nucleotides at nt 4137 (Fig. 3.14). This A4137C mutation resulted in a tyrosine  
cysteine substitution at amino acid position 277 (Y277C) of the ND1 subunit. In clone 
D4, a C to T base substitution was detected at nt 11496 (Fig. 3.15). This C11496T 
mutation causes a leucine  phenylalanine substitution at amino acid 246 (L246F) of 
the ND4 subunit.  
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Table 3.4. Common mutations in MCF-7 clones with respect to human mtDNA sequence. 
(NCBI, version February 2006). 
 
Nucleotide 
position 
NCBI 
(21 Feb 2006) 
MCF-7 clones Gene Amino acid 
change 
73 G A D Loop -- 
150 T C D Loop -- 
195 C T D Loop -- 
303 C Deletion D Loop -- 
410 A T D Loop -- 
2354 C T 16S rRNA -- 
2485 C T 16S rRNA -- 
2708 G A 16S rRNA -- 
5581 C T Intergenic -- 
5896 C Insertion COX I Frameshift 
6777 T C COX I Syn 
7029 T C COX I Syn 
8702 G A ATPase 6 S  N 
9378 G A COX III Syn 
9541 C T COX III Syn 
9967 G A COX III V  I 
10399 G A ND3 A  Y 
10820 G A ND4 S  N 
10874 C T ND4 P  L 
11018 C T ND4 A  V 
11720 A G ND4 D  G 
11723 C T ND4 S  L 
12706 T C ND5 F  L 
12851 G A ND5 S  N 
13261 T C ND5 S  P 
14213 C T ND6 Syn 
14320 T C ND6 ND 
14581 G A ND6 Syn 
14767 T C Cyt b Syn 
14906 A G Cyt b Y  C 
15933 C T tRNA
Thr 
-- 
16149 C T D Loop -- 
16173 C T D Loop -- 
16184 C Deletion D Loop -- 
16185 C A D Loop -- 
16191 C T D Loop -- 
16225 T C D Loop -- 
16322 T C D Loop -- 
 
NCBI = National Center for Biotechnology Information. rRNA, ribosomal RNA; COX, 
cytochrome c oxidase; ATPase, ATP synthase; ND, NADH dehydrogenase; cyt b, cytochrome 
b;  tRNA, transfer RNA; Syn, synonymous mutation; n/a, not applicable. 
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Table 3.5. Summary of the single nucleotide polymorphisms (SNPs) detected in three 
clones.  
 
Clone Mutation Gene  Amino acid change Heteroplasmy  
B12 G2480T h16S rRNA n/a 29.2% 
B12 C2513G h16S rRNA n/a 42.9% 
B12 A2520T h16S rRNA n/a 55.1% 
B12 C14263G hND6 D138H 35% 
B12 C9527T hCOX III A107S 15.8% 
D4 C11496T ND4 L246F - 
D9 A4137G hND1 Y277C 50% 
 
h, heteroplasmy; n/a, not applicable. rRNA, ribosomal RNA; ND, NADH dehydrogenase. 
The number in between the base refers to the nucleotide position. The number in between the 
amino acid abbreviation refers to the residue position. Heteroplasmy refers to the amount of 
mutant DNA in percentage. 
 
 
  Fig. 3.11-3.14 show chromatograms of well-resolved peaks. The peaks 
were well-defined with nice even spacing between them. These peaks were consistent 
and reproducibly obtained in every sequence analysis. In addition, there was little 
background noise present at the peak baselines. However, these noise peaks were not 
reproducible and consistent. They frequently showed indistinct crests and troughs and 
did not interfere with the proper base calling. The secondary peaks running above, 
under or overlapped the main peaks indicated heteroplasmies. These peaks were 
reproducible and were denoted by repeatedly distinct crest at the same point every 
sequencing. They were further confirmed by repeated sequencing from both forward 
and reverse directions to ensure reading accuracy. 
 
  Fig. 3.15 showed a chromatogram of fairly far along the sequence, 
where the peaks were no longer sharp but have begun to broaden and more rounded in 
shape. Similar chromatogram pattern was also found by Zhu et al. (2005) which 
showed a homoplasmic mtDNA mutation in breast cancer tissue at A16293G. 
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Figure 3.11. Sequencing patterns of the mutation sites in mitochondrial 16S rRNA gene 
from the three clones. There is a G to T transversion at nt 2480 (A), a C to G transversion at nt 
2513 (B), and an A to T transversion at nt 2520 (B). The presence of two peaks in B12 
indicates heteroplasmic mutation. 
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Figure 3.12. Identification of C9527T mutation in the mitochondrial COX III gene. 
 
 
 
 
 
Figure 3.13. Identification of C14263G mutation in the mitochondrial ND6 gene. 
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Figure 3.14. Identification of A4137G mutation in the mitochondrial ND1 gene. 
 
 
 
 
 
 
Figure 3.15. Identification of C11496T mutation in the mitochondrial ND4 gene. 
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3.6.   Sensitivity of heteroplasmy detection 
 
  DNA of D4, a homoplasmic individual was mixed with the DNA sample 
from a heteroplasmic individual B12 possessing a heteroplasmic A2520T mutation 
within the 16S rRNA gene (Fig. 3.16). The mixing experiments revealed that effective 
proportion of the DNA mixture were 69 : 31, 77.6 : 12.4, 93.8 : 6.2 and 97 : 3. These 
observations suggested that heteroplasmic mtDNA variants representing as low as 12% 
can be detected by ABI sequencing method (Harris et al., 2006). 
 
 
 
 
 
 
Figure 3.16. Detection of A2520T mtDNA heteroplasmy. Chromatogram showed the 
heteroplasmic sensitivity of the mixing experiments. The ratios of the mixing experiments are 
shown on the right. 
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3.7.   RNA secondary structure prediction 
 
  To investigate the possible functional effect of the mutations found in 
16S rRNA gene, prediction of their minimum free energy (MFE) secondary structures 
was performed using the RNAfold software (Hofacker 2003). Full secondary structure 
modelings were performed by inputting the entire 16S rRNA sequences. The secondary 
structure of 16S rRNA is largely determined by internal base pairing. D4 and D9 
showed concordance by presenting the same 16S rRNA secondary structure (Fig. 
3.17A). Clones D4 and D9 also share identical structure with normal human 16S rRNA 
(data not shown). However, the three substitutions (G2480T, C2513G and A2520T) 
found in B12 resulted in a dramatic change of the folding (Fig. 3.17B). The predicted 
secondary structure of B12 16S rRNA had more extended helical segments than the 
common secondary structure of D4-D9 16S rRNA. These heteroplasmic mutations are 
predicted to alter the secondary structure of the 16S rRNA molecule. The predicted 
initial free energies (dG) are -362.20 and -360.61 kcal/mole for D4-D9 and B12, 
respectively.  
 
 
3.8.   Amino acid sequence analysis 
 
  The Kyte-Doolittle scale (Kyte and Doolittle 1982) was used for 
delineating hydrophobic character of the amino acids by referring to the 
physicochemical properties of amino acid side chains. The polypeptide secondary 
structure was predicted using nnPredict software on the internet 
(http://www.cmpharm.ucsf.edu/~nomi/nnpredict.html). The results were noted in three 
classes of secondary structure: α-helix, β-strand and ‘no prediction’. The predicted 
secondary structure type for each residue is the type with the highest propensity or 
probability. 
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Figure. 3.17. Secondary structures prediction of 16S rRNA by the RNAfold software. 
Arrows indicate the location of heteroplasmic nucleotides. A, common secondary structure of 
D4 and D9 16S rRNA. B, secondary structure of B12 16S rRNA. 
A 
B 
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3.8.1.  A4137G heteroplasmic mutation in D9 
 
  The A4137G mutation found in clone D9 changed the hydrophobicity 
and volume, replacing the large, hydrophilic tyrosine with the small and less 
hydrophilic cysteine. This substitution was predicted to alter the Kyte-Doolittle 
hydropathy profile for ND1 (Table 3.6). There was also a slight change in the polarity. 
However, no change was observed in the amino acid secondary structure (Fig. 3.18). 
 
  
 
Table 3.6. Hydropathicity and polarity analysis of amino acid residue 277 of ND1. 
  
Tyrosine to Cysteine change at residue 277 
Amino acid property 
B12 and D4 D9 
Hydropathicity
a 
-1.143 -0.600 
Polarity
b 
8.157 8.057 
 
a
Hydropathicity was analysed by averaging over a window size of 7. The different properties of 
the amino acid were compared between the clones. Regions with values above 0 are 
hydrophobic in character and less likely to interact with water (Kyte and Doolittle 1982).  
bThe polarity reading denotes the charge of the amino acid. The amino acid is likely to be basic 
or acidic when the reading reaches above 10. The reading 5-7 indicates that the amino acid is 
likely to be nonpolar (Grantham 1974). 
 
 
 
                      267                                                 277                                                287   
Normal  T S L F L W  I R T A Y P R F R Y D Q L M H 
B12 and D4 T S L F L W  I R T A Y P R F R Y D Q L M H 
D9 T S L F L W  I R T A C P R F R Y D Q L M H 
B12 and D4 H H H H H E E H - -  - - - - - - - H H H H 
D9 H H H H H E E H - -  - - - - - - - H H H H 
 
Figure 3.18. nnpredict secondary structure prediction for ND1 at amino acid residue 277. 
H = α-helix, E = β-strand, - = no prediction. 
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3.8.2.  C9527T heteroplasmic mutation in B12 
 
  The C9527T mutation found in clone B12 changed the hydrophobicity 
and polarity, replacing the small, nonpolar hydrophobic alanine with the polar and 
uncharged, hydrophilic serine. This substitution was predicted to alter the Kyte-
Doolittle hydropathy profile for COX III (Table 3.7). The amino acid secondary 
structure was predicted as shown in Fig. 3.19. The result shows that the new serine 
amino acid shortens an α-helix and lengthens a β-strand. 
 
 
Table 3.7. Hydropathicity and polarity analysis of amino acid residue 107 of COX III. 
 
Alanine to Serine change at residue 107 
Amino acid property 
D4 and D9 B12 
Hydropathicity
a 
0.014 -0.357 
Polarity
 
8.000 8.157 
 
aHydropathicity was analysed by averaging over a window size of 7. The different properties of 
the amino acid were compared between the clones. Regions with values above 0 are 
hydrophobic in character and less likely to interact with water (Kyte and Doolittle 1982).  
bThe polarity reading denotes the charge of the amino acid. The amino acid is likely to be basic 
or acidic when the reading reaches above 10. The reading 5-7 indicates that the amino acid is 
likely to be nonpolar (Grantham 1974). 
 
 
 
 
                       97                                                   107                                                 117   
Normal F F W A F Y H S S L A P T P Q L G G H W P 
D4 and D9 F F W A F Y H S S L A P T P Q L G G H W P 
B12 F F W A F Y H S S L S P T P Q L G G H W P 
D4 and D9 H H E H  H   E    -    -    -    -     -  - - - - - - - - - - 
B12 H H E H  E   E    -    -    -    -     - - - - - - - - - - - 
 
Figure 3.19. nnpredict secondary structure prediction for COX III at amino acid residue 
107. H = α-helix, E = β-strand, - = no prediction. 
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3.8.3.  C11496T homoplasmic mutation in D4 
 
  The C11496T mutation found in clone D4 causes slight changed in the 
hydrophobicity and polarity (Table 3.8). The amino acid secondary structure was 
predicted as shown in Fig. 3.20. The result shows that the new phenylalanine amino 
acid replaces three α-helices with β-strands. 
 
 
 
Table 3.8. Hydropathicity and polarity analysis of amino acid residue 246 of ND4. 
 
Leucine to Phenylalanine change at residue 246 
Amino acid property 
B12 and D9 D4 
Hydropathicity
a 
1.529 1.386 
Polarity
 
6.500 6.543 
 
a
Hydropathicity was analysed by averaging over a window size of 7. The different properties of 
the amino acid were compared between the clones. Regions with values above 0 are 
hydrophobic in character and less likely to interact with water (Kyte and Doolittle 1982).  
bThe polarity reading denotes the charge of the amino acid. The amino acid is likely to be basic 
or acidic when the reading reaches above 10. The reading 5-7 indicates that the amino acid is 
likely to be nonpolar (Grantham 1974). 
 
 
 
                      236                                                  246                                                  256   
Normal L K L G G Y G M M R L T L I L N P L T K H 
B12 and D9 L K L G G Y G M M R L T L I L N P L T K H 
D4 L K L G G Y G M M R F T L I L N P L T K H 
B12 and D9 H H H - - - - H   H  E   E   E   E   H - - - H - - - 
D4 H H H - - - - E    E  E   E   E   E   E    - - - H - - - 
 
Figure 3.20. nnpredict secondary structure prediction for ND4 at amino acid residue 246. 
H = α-helix, E = β-strand, - = no prediction. 
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3.8.4.  C14263G heteroplasmic mutation in B12 
 
  The C14263G mutation found in clone B12 changed the hydrophobicity, 
polarity, volume and acidity. The polar, acidic aspartate was replaced by the bigger, 
polar, basic histidine. This substitution was predicted to alter the Kyte-Doolittle 
hydropathy profile for ND6 (Table 3.9). The amino acid secondary structure was 
predicted as shown in Fig. 3.21. The predicted change in the ND6 subunit shows that 
the new histidine amino acid extends an additional β-strand. 
 
 
 
Table 3.9. Hydropathicity and polarity analysis of amino acid residue 138 of ND6. 
 
Aspartate to Histidine change at residue 138 
Amino acid property 
D4 and D9 B12 
Hydropathicity
a 
-0.643 -0.600 
Polarity
 
9.029  8.657 
 
aHydropathicity was analysed by averaging over a window size of 7. The different properties of 
the amino acid were compared between the clones. Regions with values above 0 are 
hydrophobic in character and less likely to interact with water (Kyte and Doolittle 1982).  
b
The polarity reading denotes the charge of the amino acid. The amino acid is likely to be basic 
or acidic when the reading reaches above 10. The reading 5-7 indicates that the amino acid is 
likely to be nonpolar (Grantham 1974). 
 
 
 
                      128                                                  138                                                  148   
Normal E G E G S G L I R E D P I G A G A L Y D Y 
D4 and D9 E G E G S G L I R E D P I G A G A L Y D Y 
B12 E G E G S G L I R E H P I G A G A L Y D Y 
D4 and D9 E - - - - - - E   E   -     -    - - - - - - E H H H 
B12 E - - - - - - E   E   E    -    - - - - - - E H H H 
 
Figure 3.21. nnpredict secondary structure prediction for ND6 at amino acid residue 138. 
H = α-helix, E = β-strand, - = no prediction. 
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3.9.   Enzyme assays 
 
  Enzyme biochemical studies were carried out to determine the impact of 
those mtDNA mutations on respiratory enzyme activities. The mitochondria 
concentrations of cell extracts from B12, D4 and D9 cells were determined using 
Bradford assay (see Appendix 3). Calculations of enzyme activity were based on the 
linear portions of the reaction rates. Figure 3.23 shows the mean values of the 
mitochondrial marker citrate synthase (CS) activity. There was a significant decrease 
(4-fold) in citrate synthase activity of clone B12 compared to clone D4. Table 3.10 
summarises the mitochondrial OXPHOS enzyme-specific activities of the three clones. 
The result showed that defective OXPHOS was associated with specific mutation of 
mtDNA in individual clones. Nevertheless, respiratory complex activities directly 
reflect the electron transfer capacity. The enzymatic activities of all the enzyme assays 
were standardised with reference to CS, which was generally accepted as an indicator 
for the number and/or volume of mitochondria in a mitochondrial preparation 
(DiDonato et al., 1993). Hence, the ratio of respiratory complex/CS activities would 
indicate whether the change in enzyme activity was directly related to the specific 
mtDNA mutation, or was due to impairment in electron transfer chain activities (Ruiz-
Pesini et al., 1998).  
 
  As shown in Figure 3.23, there was variation in the mean values of the 
five respiratory chain complexes upon normalisation to CS activity. One-way ANOVA 
and post hoc Tukey’s HSD test were used to determine the statistical significance of the 
difference in the electron transport activities of respiratory enzymes in mitochondria 
among the three clones (Table 3.11). A p-value < 0.05 was accepted as the level of 
statistical significance. After correction for CS, there were statistically significant 
differences in all enzymes activities between clones B12 and D4. An increase in 
complex I and decreases in complex II, III, IV and V of clone B12 were observed 
compared to D4. However, no statistically significant differences were observed 
between clones B12 and D9 in citrate synthase, complex II, III and IV enzymes 
activities. Although statistically insignificant, the overall results obtained showed that 
the activities of respiratory chain complexes were diminished with respect to mtDNA 
mutation in the clones. 
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Figure 3.22. Citrate synthase activity in clones B12, D9 and D4. Citrate synthase activity 
was determined by the method of Shepherd and Garland (1969), and represented as nmol/mg 
protein/min. The data represents as mean ± SD of three different measurements. 
 
 
 
 
 
Table 3.10. Mitochondrial OXPHOS enzyme-specific activities in MCF-7 clones. Results 
are expressed as nmol/min/mg protein. The data are shown as mean value ± SD (n=3). 
 
 Complex I Complex II Complex III Complex IV Complex V 
B12 691.9 ± 74.5 947.1 ± 225.9 207.7± 43.7 88.8 ± 16.1 186.7 ± 39.5 
D9 301.4 ± 62.0 1389.4 ± 329.9 354.7 ± 40.9 186.1 ± 24.3 351.1 ± 63.9 
D4 569.7 ± 37.1 10345.6 ± 873.9 1064.6 ± 79.6 612.8 ± 34.1 1751.7 ± 430.3 
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Table 3.11. Statistical significance analysis of citrate synthase (CS) and the normalised 
mitochondrial respiratory enzyme activities in B12, D4 and D9 clones. Pairwise between-
group
 
comparisons showing p-values between clones. 
 
Respiratory enzyme Clone D4 D9 
B12 p < 0.001 NS 
Citrate synthase (CS) 
D4  p < 0.001 
B12 p < 0.01 p < 0.01 
Complex I/CS 
D4  p < 0.01 
B12 p < 0.001 NS 
Complex II/CS 
D4  p < 0.01 
B12 p < 0.05 NS 
Complex III/CS 
D4  NS 
B12 p < 0.05 NS 
Complex IV/CS 
D4  NS 
B12 p < 0.01 p < 0.05 
Complex V/CS 
D4  p < 0.05 
 
I, complex I (NADH-ubiquinone oxidoreductase); II, complex II (succinate dehydrogenase); III, 
complex III (ubiquinol-cytochrome c oxidoreductase); IV, complex IV (cytochrome c oxidase); 
V, complex V (ATP synthase). Statistical significances were assessed by one-way ANOVA and 
Tukey’s HSD test. Statistical significance was set at p-value < 0.05. NS, not significant. 
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3.10.  Effect of extracellular ATP on cell proliferation 
 
  In order to determine whether the slow growth rate observed in clone 
B12 was due to low ATP production by these cells, B12 cells were cultured in the 
presence of exogenous ATP at different concentrations (0 µM, 50 µM, 100 µM and 1 
mM). D4 (fastest growth) was cultured without exogenous ATP as a reference for 
comparison. Phase contrast micrographs showing morphology of the cells were taken 
48 h after seeding (Fig. 3.24). The cell density increased with increasing ATP 
concentrations. The cell population doubling times were determined by daily cell 
number estimation. Figure 3.25 shows the growth curve for each treatment.  Table 3.12 
summarises the mean doubling time of the cells growth under different conditions. A 
one-way ANOVA was used as a parametric approach to assess the effect of 
extracellular ATP on the cells. There was a statistically significant difference in growth 
rates when different ATP concentration was supplemented to the culture media [F(4,10) 
= 80.55, p < 0.0001]. Post-hoc comparisons using the Tukey HSD test was carried out 
to determine the significance of the differences between pairs in the five groups (see 
Appendix 3). Statistical significance was assessed by one-way analysis of variance 
(ANOVA). Table 3.13 shows the p-values for different comparisons. No significant 
effect on the growth rate was observed when the cells were cultured in the presence of 
50 µM ATP. However, a clear and reproducible effect on the growth rate was observed 
at 100 µM, while a maximal response was observed at 1 mM.  
 
 
 
Table 3.12. Doubling time of B12 (at different ATP concentration) and D4 (without ATP). 
 
Cell Mean doubling time (h) 
D4 21.6 ± 1.4 
B12 (no ATP) 40.8 ± 2.4 
B12 – 50 µM ATP 36 ± 2.4 
B12 – 100 µM ATP 26.4 ± 2.4 
B12 – 1 mM ATP 19.2 ± 1.4 
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B12 – no ATP 
 
B12 treated with 50 µM ATP 
 
  
B12 treated with 100 µM ATP 
 
B12 treated with 1 mM ATP 
 
 
D4 – no ATP 
 
 
Figure 3.24. Growth morphology and characteristic showing the effect of extracellular 
ATP on cultured cells. 48 h after seeding at 1 x 104 cells/ml/well. The cell proliferation 
increased with the concentration of extracellular ATP. Phase contrast. Scale bar 50 µm.      
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Table 3.13. Tukey HSD test of B12 (at different ATP concentration) and D4 (without 
ATP). Pairwise between-group
 
comparisons showing p-values between clones. Statistical 
significance was set at p-value < 0.05. NS, not significant. 
 
 
B12 
(50 µM ATP) 
B12 
(100 µM ATP) 
B12 
(1mM ATP) 
D4 
(no ATP) 
B12  
(no ATP) 
NS < 0.001 < 0.001 < 0.001 
B12 
(50 µM ATP) 
 < 0.001 < 0.001 < 0.001 
B12 
(100 µM ATP) 
  < 0.05 NS 
B12 
(1mM ATP) 
   < 0.01 
 
 
3.11.  RNA extraction from cell cultures 
 
  In order to investigate the effect of exogenous ATP on cellular function, 
RNA was extracted from clone B12 grown in different ATP concentrations, clone D4 
and D9. The RNA was then separated and analysed on a denatured gel. Figure 3.26 
shows 28S and 18S rRNA bands. The total RNA samples were then tested for genomic 
DNA contamination by direct PCR using the RNA preparation as templates before the 
RNA was used for cDNA synthesis (data not shown). 
 
 
 
Figure 3.26. Representative gel image of total RNA. Total RNA were separated by gel 
electrophoresis on denatured 1% agarose-formaldehyde gel. Bright 28S and 18S rRNA bands; 
and an even mRNA smear were present. Lane 1: B12. Lane 2: B12 treated with 100 µM ATP. 
Lane 3: B12 treated with 1 mM ATP. Lane 4: D4. Lane 5: D9. 
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3.12.   Comparative reverse-transcription PCR (RT-PCR) 
 
  Normalisation based on 18S rRNA was used to correct for differences 
arising from variation in the quality and quantity of starting RNA in each assay. 18S 
rRNA was chosen over β-actin and glyceraldehydes-3-phosphate dehydrogenase 
(GAPDH) because expression of 18S rRNA under different experimental conditions 
was not found to be affected by exogenous ATP concentration in the culture media 
(Finnegan 1993; Yamada 1997). Expression of the selected genes was expressed 
relative to 18S rRNA. Figure 3.27 shows the RT-PCR products of four selected genes. 
The band intensities of the RT-PCR products were found to be increased with 
increasing amount of ATP added to the culture medium. D4, which was the fastest 
growing clone showed the lowest band intensity as compared to D9, the moderately 
fast growing clone. The levels of expression of the genes relative to 18S rRNA were 
further determined by using GeneTools as described in ‘Materials and methods’. Figure 
3.28 shows a consistent correlation between the ATP concentration and B12 gene 
expression. To rule out the contamination by genomic DNA, total RNA samples 
without RT reaction were subjected to PCR amplification. However, no DNA fragment 
was detected (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 RESULTS 
 
71 
 
 
 
 
Figure 3.27. Representative results of RT-PCR analysis. RT-PCR gel image analysis of 
MCF-7 clone cells cultured with or without extracellular ATP treatment. Approximately 2 µg 
of each treated RNA was used in the RT-PCR reaction for the amplification of 16S rRNA, ND1, 
ND4, ND6 and COX III. All PCR amplifications were performed three times. The relative level 
of mRNA of each gene was analysed as described in “Materials and Methods”. One-tenth of 
each RT-PCR reaction was assessed on a 1% agarose gel and stained with ethidium bromide. 
The mRNA level of housekeeping gene, 18S rRNA, was used as an internal standard for 
sample normalisation. Lane 1: B12. Lane 2: B12 treated with 100 µM ATP. Lane 3: B12 
treated with 1 mM ATP. Lane 4: D4. Lane 5: D9. 
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4.1.  Cell morphology and growth characteristics 
 
  MCF-7 cell line was established from the pleural effusion of a patient 
who was diagnosed with adenocarcinoma of the breast (Soule et al. 1973). This cell 
line has been shown by Resnicoff et al. (1987) to be highly heterogeneous with the 
ability to generate clonal variation. Resnicoff and coworkers demonstrated that MCF-7 
cells could be fractionated in Percoll gradients to yield several subpopulations with 
different characteristics: variability in growth rate; DNA synthesis; expression of ras 
oncogene-encoded protein p21, estrogen receptors, and carcinoembryonic antigen 
(CEA). Interestingly, one of the minor fractions appeared to contain the stem cells. In 
addition to the phenotypic variability, these findings suggested that this cell line may be 
also prone to genetic heterogeneity. This is likely due to spontaneous mutation in vitro, 
which could be associated with the higher rate of cell proliferation (cited in Freshney, 
2000).  
 
  In the present study, six clones (B5, B12, D4, D9, E1 and E8) were 
isolated and established from single cells obtained by serial dilution of a MCF-7 stock 
culture. When the six isolated clones were grown individually, the clones demonstrated 
variance in cell morphology and growth characteristics. Most cells clumped together 
and formed discrete clusters before reaching confluency (Fig. 3.1A, C, D, E, F). This is 
a typical morphology of cancer cells. In contrast, clone B12 was more scattered and it 
was likely due to contact inhibition (Fig. 3.1B). As for doubling time, clone D4 was the 
fastest growing and clone B12 was the slowest; the others attained intermediate rates 
(Table 3.1). These results supported the findings of Resnicoff et al. (1987). However, 
Resnicoff and coworkers did not investigate the cells at the genomic level to account 
for the observed differences, although it is likely that the growth variability is 
influenced by different genomic background. 
 
  Cells may take longer to recover when reseeded if they are withdrawn 
from the cycle due to delayed subculture (Freshney, 2000). Hence, the cells were 
subcultured as soon as they reach 80% confluency. When the clones were subcultured, 
they showed a consistent growth rate characteristic of a specific clone and did not 
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change over different passages. It is, therefore, hypothesized that these clones with 
different growth characteristics may represent different sublines, although they 
coexisted in the stock culture. The observed variations in growth characteristics in 
different clones may be resulted from mutational changes in nuclear and/or 
mitochondrial genes. The present study focused on mutational analyses of the 
mitochondrial genome because mitochondria are the powerhouse of a cell. They 
provide energy for all the cellular functions including growth and cell division. Due to 
time constraint, the nuclear genome was not included in this study. When a mutation in 
the mtDNA was identified, the effect of the mutation was determined by investigating 
the oxidative phosphorylation activites of the clones.  
 
 
4.2.   Mutational analysis 
 
  In the present study, comparison of the clones B12, D4 and D9 has 
revealed a total of seven mutations by direct DNA sequencing: three within 16S rRNA 
gene and one each within the amino acid coding regions of ND1, COX III, ND4 and 
ND6 genes, respectively (Table 3.5). These results suggested that the clones were 
genetically different in the mitochondrial genome. Six out of the seven mutations were 
in a heteroplasmic state within the sensitivity of the method (Harris et al., 2006). 
Heteroplasmy, the presence of a mixture of normal and mutant mtDNA, may be a 
phase in the establishment of a pathogenic mutation. This phenomenon is of particular 
significance if it results in a change of a highly conserved nucleotide base or amino 
acid residue (Riordan-Eva and Harding, 1995; Chinnery and Schon, 2003). 
 
 
4.2.1.  Amino acid change in ND1 
 
  Homology studies revealed that Tyr
277
 (A4137, ND1) is highly 
conserved in eukaryotes (Table 4.1). Tyrosine is a polar, hydrophilic amino acid with a 
large benzene ring side chain. It is less strictly segregated from water due to the 
possession of a polar -OH group. Cysteine is a small, polar molecule which is less 
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hydrophilic than tyrosine. The replacement of tyrosine (with a large side chain) by 
cysteine (with a small side chain) is very likely to destabilise the protein fold 
conformation. Hydropathicity and polarity analysis showed that there is a slight change 
in the parameters (Table 3.6). Residue 277 in clone D9 becomes less hydrophilic in 
comparison with clones B12 and D4. However, there is no significant alteration in the 
secondary structure in ND1 subunit as a result of Cys
277
 (Fig. 3.18). As the conserved 
nature of Tyr
277
 suggests that this mutation may influence the function of complex I in 
most eukaryotes, variant amino acids are, nevertheless, also found in Drosophila 
yakuba and Pichia canadensis. Hence, further studies would be required to investigate 
the effect of this mutation. 
 
 
Table 4.1. Amino acid homology showing comparison of residue 277 between species. 
Homology analysis was done by using the Basic Local Alignment Search Tool (BLAST) at the 
National Center for Biotechnology Information (NCBI) website 
(http://www.ncbi.nlm.nih.gov/blast). Residues 277 in the species are in bold. 
 
Species Amino acid sequence 
NCBI reference 
(accession number) 
                                        277  
Clone D9 I R T A C P R F R this study 
Clones B12 and D4 I R T A Y P R F R this study 
Human I R T A Y P R F R NP_536843 
Chimpanzee I R T A Y P R F R NP_008186 
Iguana V R A S Y P R F R NP_115836 
Xenopus laevis V R A S Y P R F R NP_008134 
Chicken I R A S Y P R F R NP_006915 
Bovine I R A S Y P R F R YP_209205 
Mouse I R A S Y P R F R NP_904328 
Zebrafish M R A S Y P R F R NP_059331 
Drosophila yakuba A R G T L P R F R NP_006914 
Pichia canadensis V R A S F P R L R NP_038213 
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4.2.2.  Amino acid change in COX III 
 
  Homology studies showed that Ala
107
 (C9527T, COX III) in clone B12 
is highly conserved in vertebrates although serine is also found in two lower organisms 
(Table 4.2). Nevertheless, this invariant Ala
107 
residue is believed to be residing in the 
conserved region and formed part of the putative membrane-spanning segment III of 
the COX III polypeptide in eukaryotes (Haltia et al., 1991). Site-directed mutagenesis 
study of Haltia et al. (1991) demonstrated that this region is important for COX III to 
serve in the biosynthesis of functional proton-translocating cytochrome c oxidase 
complex. Hence, a substitution at this position with a different amino acid is likely to 
disrupt its biological function. 
 
  Alanine is a non-polar, hydrophobic amino acid. It is less strictly 
segregated from water due to its smaller size. Serine is an uncharged, hydrophilic 
amino acid with a polar –OH group. As the nature of the amino acid side chains has 
significant influence on the topography of the protein, these changes in chemical 
properties of residue 107 would be expected to significantly alter the hydropathicity 
and polarity of the COX III polypeptide. Analyses of these parameters revealed that 
this region does become more hydrophilic and there is an increased in polarity (Table 
3.7). Secondary structure analysis predicted a decrease in the length of transmembrane 
α-helix and an increase in the peripheral β-strand (Fig. 3.19).  
 
  In membranous polypeptides, α-helices and β- strands pack by stacking 
their amino acid side chains. α-helices act as the polypeptides structural support, 
providing rigidity within the membrane, whereas β-strands allow the polypeptide to be 
flexible in one direction (Fersht, 1985). Hence, the polypeptide with increased 
flexibility is likely to obstruct the function of COX III.  
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Table 4.2. Amino acid homology showing comparison of residue 107 between species. 
Homology analysis was done by using the Basic Local Alignment Search Tool (BLAST) at the 
National Center for Biotechnology Information (NCBI) website 
(http://www.ncbi.nlm.nih.gov/blast). Residues 107 in the species are in bold. 
 
Species Amino acid sequence NCBI reference 
(accession number) 
                                       107  
Clone B12 H S S L S P T P Q this study 
Clones D4 and D9 H S S L A P T P Q this study 
Human H S S L A P T P Q NP_536849 
Chimpanzee H S S L A P T P Q NP_008192 
Chicken H S S L A P T P E NP_006921 
Zebrafish H S S L A P T P E NP_059337 
Bovine H S S L A P T P E YP_209211 
Iguana H S S L A P T P E CAC37089 
Xenopus laevis N S S L A P T Y E NP_008140 
Mouse H S S L V P T H D NP_904334 
Drosophila yakuba H S S L S P A I E NP_006907 
Pichia canadensis H S A M S P A I E NP_038214 
 
 
 
4.2.3.  Amino acid change in ND4 
 
  Homology studies showed that Leu
246
 (C11496T, ND4) in clone D4 is 
poorly conserved within eukaryotes (Table 4.3). The limited conservation of Leu
246
 
suggests that it may have little functional significance in the ND4 polypeptide. Both 
leucine and phenylalanine are non-polar hydrophobic amino acids. However, 
phenylalanine contains a benzene ring and has larger side chain than leucine. The 
stability of proteins mainly arises from the formation of intramolecular hydrogen bonds 
and the reduction in the surface area accessible to solvent that occurs upon folding 
(Garrett and Grisham, 2005). Hence, the replacement of a small side chain by a larger 
side chain may be unfavourable to the fold conformation of ND4 polypeptide. This 
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change in chemical properties between the amino acids is reflected in the 
hydropathicity analysis, as residue 246 becomes less hydrophobic in clone D4 
compared to clones B12 and D9 (Table 3.8). Polarity of the residue 107 is, however, 
not significantly altered by the leucine to phenylalanine change. 
 
  Secondary structure analysis predicted that Phe
246
 altered the secondary 
structure of ND4 polypeptide by replacing three transmembrane α-helices with three 
peripheral β-strands (Fig. 3.20). Hence, an increase in the peripheral β-strands may 
result in a more flexible polypeptide, which in turn may have an effect on the function 
of complex I. The effect of this mutation on the function of complex I remains to be 
elucidated. 
 
 
Table 4.3. Amino acid homology showing comparison of residue 246 between species. 
Homology analysis was done by using the Basic Local Alignment Search Tool (BLAST) at the 
National Center for Biotechnology Information (NCBI) website 
(http://www.ncbi.nlm.nih.gov/blast). Residues 246 in the species are in bold. 
 
Species Amino acid sequence NCBI reference 
(accession number) 
                                       246  
Clone D4 G M M R F T L I L this study 
Clones B12 and D9 G M M R L T L I L this study 
Human G M M R L T L I L NP_536852 
Chimpanzee G M M R L T L I L NP_008195 
Pichia canadensis A I I R L I L I N NP_038220 
Bovine G M L R I T L I L YP_209214 
Mouse G M I R I S I I L NP_904337 
Iguana G I I R I T L T L NP_115845 
Xenopus laevis G I I R I S I T L NP_008143 
Chicken G I M R V T L L M NP_006924 
Drosophila yakuba G L L R V I N F L NP_006910 
Zebrafish G M M R M M V M L NP_059340 
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4.2.4.  Amino acid change in ND6 
 
  Homology studies showed that Asp
138
 (C14263G, ND6) in clone B12 is 
well conserved in vertebrates (Table 4.4). Both aspartate and histidine are characterised 
by being polar and hydrophilic amino acids, with histidine being larger in size, less 
hydrophilic and polar than aspartate (Table 3.9). Secondary structure analysis predicted 
the extension of β-strand in clone B12 (Fig. 3.21), which is likely to increase the 
flexibility of ND6 polypeptide. Aspartate is believed to play several important roles in 
nucleotide biosynthesis. Nitrogen atom derived from –NH2 group of aspartate is used to 
form ribonucleotides (purine and pyrimidine rings), precursors to DNA and RNA 
(Garrett and Grisham, 2005). In addition, aspartate interacts with the metal ions from 
the incoming nucleotide added during the elongation of a polynucleotide chain by DNA 
polymerase (Doublie et al., 1998; Kiefer et al., 1998). Hence, the alteration of aspartate 
to histidine at residue 138 is very likely to affect the function of complex I. 
 
 
Table 4.4. Amino acid homology showing comparison of residue 138 between species. 
Homology analysis was done by using the Basic Local Alignment Search Tool (BLAST) at the 
National Center for Biotechnology Information (NCBI) website 
(http://www.ncbi.nlm.nih.gov/blast). Residues 138 in the species are in bold. 
 
Species Amino acid sequence NCBI reference 
(accession number) 
 138  
Clone B12 L I R E H P I G A this study 
Clones D4 and D9 L I R E D P I G A this study 
Human L I R E D P I G A NP_536854 
Chimpanzee L I R E D P I G A NP_008197 
Chicken F A R L D F S G V NP_006927 
Zebrafish V I R A D V S G V NP_059342 
Xenopus laevis V M R G D W V G V NP_008145 
Iguana V S R S D F G G V NP_115847 
Bovine F F S E E A M G I YP_209216 
Mouse V M L E G G I G V NP_904339 
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4.2.5.  RNA secondary structure prediction 
 
  The prediction using RNA fold software showed modelling structure of 
B12 appeared to be completely different from the common structure of D4 and D9 (Fig. 
3.17). Seemingly, the combined effect of mutations at G2480T, C2513G and A2520T 
had introduced significant changes in the secondary structure of the 16S rRNA 
molecule of clone B12. The predicted initial free energies (dG) are -362.20 and -360.61 
kcal/mole for D4-D9 and B12, respectively. This suggests that clone B12 is likely to 
have a lesser stable 16S rRNA secondary structure. These findings shed light on the 
possible functional effects of clone B12.  
 
  Mitochondrial 16S rRNA is an essential component of the ribosomal 
large subunit, which are responsible for protein synthesis in all living cells. The 16S 
rRNAs adopt an evolutionarily conserved secondary structure with four domains that 
appear to fold independently, and are closed by long-range base-pairing interactions 
(Klug and Cummings, 2000). Conformational conservation of rRNA is essential in 
maintaining ribosome function. Biological activity of rRNA is dependent on its 
structural conformation (Burk et al., 2002). Previous study showed that 16S rRNA 
plays a role in protein folding activity (Sulijoadikusumo et al., 2001). The secondary 
structure of the rRNA molecule is potentially the most important determinant of its 
protein folding activity. Hence, any mutations that affect the secondary structure of 16S 
rRNA is likely to disrupt its function.  
 
  Tan et al. (2002) pointed out that transcription of the mitochondrial 
genome generates two polycistronic primary transcripts that are subsequently processed 
to produce mature mRNA, rRNA and tRNA. Hence, mtDNA mutations affecting the 
folding of secondary structure of the RNA precursors could be deleterious to the 
maturation of RNA. In addition, as ribosomes are essential for translation, rRNA 
mutations may also cause major assembly defects or interfere with tRNA protection 
activity (Noller, 1991). Therefore, it is very likely that the translation of the 13 
mtDNA-encoded polypeptides will be affected, resulting in generalised OXPHOS 
deficiencies. Further molecular studies of RNA processing may be needed to elucidate 
the biological effect of these sequence variations. 
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4.3.   Enzyme assays 
   
  Oxidative phosphorylation (OXPHOS) is the final step of the energy-
producing pathway. It is mediated by mitochondrial membrane-bound enzyme 
complexes that transport electrons from NADH and FADH2 to oxygen, generating a 
proton gradient that ultimately leads to the production of ATP (Smeitink et al., 2001). 
Defects in complexes III and IV in clone B12 is likely to disrupt respiration and 
decrease the mitochondrial proton electrochemical potential gradient across the 
mitochondrial inner membrane (Fig. 4.1). As proton electrochemical potential gradient 
is the driving force for ATP synthesis, decreasing it may eventually hinder ATP 
production, as evidenced by the low activity of complex V in clone B12. In addition, 
mitochondria also affect cytoplasmic Ca
2+
 metabolism in two ways: indirectly via Ca
2+
- 
dependent ATPases to pump excess Ca
2+
 from the cytoplasm to the extracellular 
environment or intracellular Ca
2+
 depots; and directly through the mitochondrial 
membrane potential which drives the uptake of Ca
2+
 into mitochondria through a Ca
2+
-
uniporter (James and Murphy, 2002). Hence, a defective mitochondrial ATP synthesis 
may inhibit Ca
2+
 uptake, leading to a decrease in dehydrogenase activity and substrate 
supply.  The diminished substrate supply will further affect the generation of proton 
electrochemical potential gradient, hence worsening the condition.  
 
  Interestingly, these observations correlated with the results obtained from 
mutation screening and secondary structure modelling, which suggested that the 
structural changes due to heteroplasmic mutations in 16S rRNA of clone B12 at 
G2480T, C2513G and A2520T are very likely to disrupt the mitochondrial OXPHOS 
function due to aberrant gene products, in which the complexes involved in the 
respiratory chain. These findings indicate that the secondary structure of 16S rRNA is 
most likely a determinant of the changes in OXPHOS activity. Nevertheless, the exact 
mechanism of interaction remains unclear. 
 
  Furthermore, COX III has a distinct role in the assembly of the 
functional oxidase and acts as a structural stabilizer of the mature oxidase complex IV 
(Haltia et al., 1991). The C9527T mutation found in clone B12, causing COX III more 
prone to structural perturbation and may result in poorly assembled cytochrome c 
oxidase complex. The conformational change of the complex is likely to cause a lower 
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Figure 4.1. The effect of mtDNA mutations on oxidative phosphorylation. The respiratory 
chain transfers electrons from reduced substrates to oxygen and uses the difference in redox 
potential to pump protons across the inner membrane to establish a proton electrochemical 
potential gradient which is then used to drive ATP synthesis by ATP synthase (complex V). 
Inhibition of complex I would oxidise the respiratory chain, while disruption of complexes III, 
IV or V would lead to a complete or partially reduced respiratory chain. The point at which 
electron transport is blocked will affect the redox state of electron carriers, such as ubiquinone 
and cytochrome c. The accumulation of NADH from inhibition of the respiratory chain will 
also affect cell redox balance. Additionally, a disruption of ATP supply would inhibits Ca
2+
 
uptake, leading to a decrease in dehydrogenase activity and substrate supply, thus worsen the 
whole chain reaction. O2 = Superoxide; Q = ubiquinone; QH2 = ubiquinol; Cox = 
ferricytochrome c; Cred = ferrocytochrome c; ∆µH+ = proton motive force; ∆ψm = mitochondrial 
membrane potential; Pi = phosphate. Adapted from James and Murphy (2002). 
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affinity of cytochrome for substrate ubiquinol. As a result, there is a decrease in 
complex III activity in clone B12. This may lead to an impaired proton translocation 
and a deficit in electrochemical gradient, which ultimately may hinder proper ATP 
production. mtDNA mutations leads to a deficiency in mitochondrial enzyme activities 
and a decrease in ATP synthesis have also been reported previously (Heddi et al., 1999; 
James et al., 1999; Hsieh et al., 2001). Based on these findings, it is tempting to 
conclude that the presence of mtDNA mutations is associated with reduction in 
OXPHOS activity and ATP production. The deficiency in mitochondrial ATP synthesis 
may account for the slow growth in clone B12. The heteroplasmic mtDNA mutations 
found in clone B12 could be deleterious. 
 
  The inability to assemble correctly functioning mitochondrial proteins 
may cause an upregulation of the production of many mitochondrial polypeptides or 
stimulate the biogenesis of the whole organelle, in an attempt to compensate for an 
energy deficit (James and Murphy, 2002). This was shown by a significant decrease in 
the activity of nuclear-encoded mitochondrial enzyme citrate synthase (CS) in clone 
B12 compared to clones D4 and D9 (Fig. 3.22). These could probably reflect a 
compensatory mechanism for responding to a reduced energy metabolism in these cells 
as a consequence of mutations in 16S rRNA gene found in clone B12. Similar result 
was also observed by Bhat (2002), demonstrating a decrease in CS activity in estrogen-
induced hamster kidney tumours compared to untreated controls. 
 
  Nonetheless, clone D4 and D9 exhibited 3-fold decrease in complex I 
activity compared to clone B12 (Fig. 3.23). These findings suggest that the mutations 
C11496T in ND4 and A4137T in ND1, in clone D4 and D9, respectively, are likely to 
affect the respiratory function of complex I. The exact function of the mitochondrially 
encoded complex I subunits is unclear, but it is likely that they are involved in proton 
translocation and contribute to the quinone binding site (Friedrich et al., 1990). 
However, despite this diminished complex I activity, the ultimate ATP production as 
reflected in complex V activity of both D4 and D9 are relatively higher than clone B12. 
This suggests that the lower complex I activity is not sufficient to compromise ATP 
production. The mutations in clone D4 and D9 are likely to fall within their mutation 
tolerance levels (threshold effect), at which point they could compensate for the effect 
of the mutations. Hence, an active ATPase in the absence of functioning complex I may 
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still form a membrane potential by acting as an H
+
 pump and consuming glycolytically 
generated ATP (James and Murphy, 2002). This could probably explain why cell 
growth of clone D4 (fastest growth) and D9 (moderate growth) were not compromised 
compared to clone B12 (slowest growth). 
 
  Furthermore, the OXPHOS system is under the control of two separate 
genetic systems, which involves interplay between the mitochondrial and the nuclear 
genomes (Smeitink et al., 2001). Hence, an alternative explanation to this observation 
may be that there is a cooperative interaction of nuclear genes in clone D4 and D9 with 
complex II. It is known that many nuclear proteins are required for mtDNA replication, 
transcription and translation (Brown and Wallace, 1994). Thus, many aspects of 
mitochondrial disease may be related to the structure, variation, and regulation of 
nuclear genes involved in OXPHOS. This conjecture is supported by the findings 
showing relatively higher nuclear encoded complex II activity in clone D4 and D9. The 
low complex II activity in clone B12 may suggest the presence of mutations in the 
nuclear genome, since complex II is solely encoded by nuclear genome. Seemingly, 
mutations in nuclear genes can exert their phenotypic effects by indirectly inactivating 
OXPHOS or destabilizing the mtDNA. The specific nuclear and mitochondrial roles 
and their possible relationships, however, have yet to be established. 
 
 
4.4.   Effect of extracellular ATP on cell proliferation 
 
  In the present study, mutational and enzymatic analyses suggest that 
energy production in B12 may be compromised. If this is true, would supplementing 
the culture medium with extracellular ATP enhance the growth rate of the slow growth 
clone? In the present study, extracellular ATP was found to stimulate proliferation 
significantly in the slowest growing clone B12 as compared to untreated cells when 
ATP concentration was greater than 100 µM ATP (Fig. 3.25, Table 3.12). At 1 mM 
ATP, clone B12 had a faster growth rate than the fastest clone D4 without ATP 
supplement. This observation is consistent with the findings of Dixon et al. (1997) who 
reported that ATP induced cell proliferation in MCF-7 breast cancer cells in vitro. 
Dixon et al. also demonstrated that ATP acted on its mitogenic effect through 
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interaction with cell surface receptors known as P2-purinoceptors. It is believed that 
activation of these designated purigenic P2 receptors by ATP leads to the release of 
intracellular Ca
2+
 and hence inducing cell growth.  
 
  Several investigators have also observed stimulation of proliferation by 
purinergic receptor agonists in other cell types in vitro, including renal epithelial cells 
(Paller et al., 1998), human ovarian cancer cell line OVCAR-3 (Popper and Batra, 
1993), aortic smooth muscle cells (Wang et al., 1992), brain astrocytes (Hindley et al., 
1994), mesangial cells (Schulze-Lohoff et al., 1992, 1995, 1996; Huwiler and 
Pfeilschifter, 1994), and human melanomas (White et al., 2005). In addition, in vitro 
studies of isolated proximal tubule segments suggested that exogenous ATP is 
sequentially degraded to ADP, AMP and finally adenosine by ectonucleotidases before 
restoring intracellular ATP levels (Mandel et al., 1988).  
 
  In contrast to the observations in the present study, extracellular ATP 
was found to inhibit cell proliferation. The anti-cancer activity of adenine nucleotides 
was first described by Rapaport (1983). It is reported that low levels of extracellular 
ATP significantly inhibit the growth of human tumour cells in vitro (CAPAN-1, a 
pancreatic adenocarcinoma; HT29, a colon adenocarcinoma) and subsequently yield 
substantial cell killing by initiating arrest in the S phase of the cell cycle. Furthermore, 
the role of extracellular ATP in attenuation of cell growth via G-protein-coupled P2Y2 
receptors were also reported in endometrial cancer cells (Katzur et al., 1999) and 
human ovarian cancer cells, EFO-21 and EFO-27 (Schultze-Mosgau et al., 2000).  
 
  In addition, Rapaport (1983) postulated that the antiproliferation induced 
tumor cell killing action is attributed to the permeabilisation of tumor cell membrane by 
extracellular ATP. Similar finding was also observed by Schulze-Lohoff et al. (1998) 
who found that the inhibition of cell proliferation through the activation of P2Z/P2X 
receptors could lead to apoptosis and necrosis of mesangial cells. Interestingly, pore 
formation was found in the plasma membrane of the mesangial cells. Schulze-Lohoff et 
al. (1998)’s observation suggested that the porous membrane is associated with the 
P2Z/P2X receptors. However, whether the pore formation is involved in the mechanism 
of cell death remains uncertain.  
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  Previously, Saribas et al. (1993) had demonstrated that ATP reversibly 
increases the plasma membrane permeability of transformed 376 mouse fibroblasts to 
macromolecules as large as 20 kDa. Presumably, ATP may cause the generation of a 
growing hole in the plasma membrane. This finding could probably account for the 
morphological change in B12 cells treated with 1 mM ATP, where the cells appeared to 
be larger in size (Fig. 3.24). The possibility is that the exogenous ATP alters the 
membrane permeability through the interaction with P2Z receptors. This postulation 
may suggest the possible occurrence of osmosis where solvent molecules move across 
the more permeable membrane from extracellular space into the cells, causing them to 
swell. However, it is not clear how the pore is formed. Whether it is due to membrane 
damage or the formation of a protein-pore complex remains to be elucidated. 
 
  In the present study, extracellular ATP has probably induced cell 
proliferation in clone B12 via the P2 receptors. Millimolar concentrations of ATP may 
also have induced the pore formation via other P2 receptors. In line with the 
observations from this present study, Batra and Fadeel (1994) and Schulze-Lohoff et al. 
(1998) had presented evidences that different P2 receptors may become functional at 
different concentrations of ATP. These findings were of particular interest, in that their 
studies suggested that the extracellular actions of ATP are likely to be cell-specific, and 
depend on the expression of P2 receptor types, as well as the amount of nucleotides in 
the extracellular space. Further investigation is required to confirm the mechanism of 
action of the specific P2 purinoceptors on these cells, and to determine whether the 
variability in cell growth can be related solely to ATP, or if other factors are also 
involved. 
 
 
4.5.   Comparative RT-PCR analysis 
 
  Given the extensive effect of extracellular ATP may have on the cells, it 
is important to determine whether extracellular ATP affects gene expression. Reverse 
transcription-PCR analysis indicated the expression of the respiratory chain complexes 
containing mutations, i.e. 16S rRNA, ND1, ND4, ND6 and COX III genes. The mRNA 
expression profile of the extracellular ATP-treated B12 cells is clearly different from 
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that of the untreated B12 cells. The PCR products of mtDNA 16S rRNA, ND1, ND4, 
ND6, COX III in clone B12 were increased substantially with ATP supplement in the 
culture medium (Fig. 3.27). This increase in transcript levels may suggest increased 
transcription rates or transcript stability. Extracellular ATP, thus, is likely to have an 
upregulating effect on the gene expression. Heddi et al. (1999) had observed an 
increased gene expression in tissues of mitochondrial disease patients. These 
researchers had delineated that high levels of mutant mtDNAs were associated with a 
high induction of the mtDNA and nuclear OXPHOS genes. Hence, it is likely that the 
mutated cells and/or tissues induce mitochondrial biogenesis to compensate for the 
metabolic deficiency due to OXPHOS impairment associated with mtDNA mutations. 
However, the effect of nuclear genes on mitochondrial function is still an open question. 
It is not clear whether other genes whose products interact with OXPHOS are also 
involved. It is also not known whether extracellular ATP alone accounts for the 
differences in gene expression between the clones. Another important question that 
arises is whether there is a causative relationship between the severity of mutations and 
level of induction. The mechanism for the compensatory induction, however, has not 
been fully characterised. 
 
 
4.6.   Future directions 
 
  The relevance of these findings to the role of mtDNA mutations in cell 
growth remains anticipating, as it highlights the potential importance of ATP in 
mitochondrial disease and carcinogenesis. Further studies are required to extend the 
observations from this study and address the mechanisms underlying the proliferative 
response to extracellular nucleotides in vitro. Also, the study of mitochondrial gene 
expression by analysing mtRNA processing and translational protein products in cell 
cultures in response to OXPHOS defects may shed light on the pathogenic role of a 
novel mtDNA mutation. Other important areas for future research include studies of 
intergenomic signaling pathways in carcinogenesis and the potential role of 
mitochondria and mtDNA mutations in the immunological surveillance of tumour cells. 
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4.7.   Conclusions  
 
  It is hypothesised that any mutation that alters a functional gene in 
mtDNA is likely to compromise cell functions by affecting OXPHOS and ATP 
production, which ultimately affect cell proliferation. In the present study, the 
important role of mitochondria in energy metabolism was determined by comparing the 
effect of mtDNA mutations on growth patterns and OXPHOS enzyme activities; as 
well as the effect of ATP supplement to culture using five different MCF-7 cell line 
derived clones. The isolated clones had shown distinct growth pattern and morphology. 
The difference in proliferation rates among the clones was ascertained by the doubling 
times. The clone’s slow growth rate was likely the result of mitochondrial mutations in 
the 16S rRNA gene, ND1, ND4, ND6 and COX III. The five heteroplasmic mutations 
found in clone B12 appeared to be deleterious to the cell by disrupting mitochondrial 
OXPHOS activities and reducing energy output.  
 
  From molecular screening and secondary structure modelling, it was 
evident that the three mutations in 16S rRNA found in clone B12 were sufficient to 
disrupt normal ribosomal function and could contribute to lowering the efficiency of 
OXPHOS. The observed variation in enzyme activities among clones may be related to 
mutations in the mtDNA, and mtDNA mutations appeared to compromise ATP 
production. This conclusion was further supported by the observation that the slow 
growth rate of clone B12 could be restored by supplementing the culture with ATP. In 
addition, the severity of the OXPHOS activities was roughly correlated with the 
number of mutations in the affected clone.  
 
  In conclusion, the results obtained from this study strongly suggest that 
cell growth largely depends on the ATP production originating in the mitochondrial 
compartment. Specific mitochondrial dysfunctions could be the underlying cause of 
growth retardation. In short, the variability in functional manifestations of mtDNA of 
clone B12 stems from a number of factors, including the nature of the mutation, 
number of mutation (mutation load) and the gene specifically affected. 
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Appendix 1: Abbreviations 
 
A  adenine or adenosine; one letter code for alanine 
A260  absorbance at wavelength of 260 nm 
A280  absorbance at wavelength of 280 nm 
bp  base pair 
C  cytosine or cytidine; one letter code for cysteine 
kDa  kilo Dalton 
DNA  deoxyribonucleic acid 
G  guanine or guanosine; one letter code for glycine 
g  gravity 
h  hours 
M  molar 
min  minutes 
nt  nucleotide 
RNA  ribonucleic acid 
rpm  revolutions per minute 
s  seconds 
T  thymine or thymidine; one letter code for threonine 
U  unit 
UV  ultraviolet 
V  volts 
v/v %  volume per volume percent 
w/v %  weight per volume percent 
 
 
Units 
g  grams 
m                     metres 
l  litres 
 
 
Prefixes 
m  milli    (1 x 10
-
3) 
µ  micro  (1 x 10
-
6) 
n  nano    (1 x 10
-
9) 
p  pico     (1 x 10
-12
) 
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Appendix 2: Recipes 
 
 
1x PBS  
 NaCl   7.6 g 
 Na2HPO4  3.8 g 
 NaH2PO4 0.42 g 
 ddH2O to 1 l    
Sterilise by autoclave (wet run at 121°C, at 100 kPa pressure). 
 
10x TBE electrophoresis buffer 
   Tris base 218 g 
   Boric acid 110 g 
   EDTA   9.3 g 
   ddH2O to 2 l 
 Adjust pH to ≈ 8 using NaOH. Autoclave (wet run at 121°C, at 100 kPa pressure). 
  
 λHE marker 
   Eco RI buffer      10 µl 
λDNA  22.42 µl 
   Hind III   0.67 µl 
   Eco RI    0.83 µl 
   ddH2O  66.08 µl 
 Incubate overnight at 37oC. Store in fridge at 4oC. 
 
 1% Agarose gel 
   Agarose 0.35 g 
   1x TBE   35 ml 
 Dissolve in microwave until clear solution. Swirl gently. 
 Allow the gel to set ≥ 30 min at room temperature. 
 
 TE 8 buffer 
   Tris-HCl 1.211 g 
   EDTA  0.372 g 
   ddH2O to 1 l.  
 Adjust pH to ≈ 8 using NaOH. Autoclave (wet run at 121°C, at 100 kPa pressure). 
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 SHE buffer 
   Sucrose  8.558 g 
   Hepes  2.383 g 
   EGTA  0.094 g 
   ddH2O to 100 ml.  
Adjust pH to ≈ 7.2 using NaOH. Store at 4
o
C. 
 
0.1% DEPC-treated water 
  1. Add 1 ml of DEPC to 1000 ml ddH2O. 
                          2. Mix well and incubate overnight at room temperature. 
                          3. Autoclave (wet run at 121°C, at 100 kPa pressure) to inactivate the  
                              remaining DEPC. 
                          4. Store at room temperature. 
 
5x MOPS running buffer 
    MOPS   20.39 g  
Sodium acetate  3.281 g 
EDTA   1.861 g 
   0.1% DEPC-treated water to 1 l.  
Adjust pH to ≈ 7 using NaOH.  
Sterilise the solution by filtration through a 0.2 micron Millipore filter. 
Store in the dark and discard if it turns yellow. 
Do not autoclave. 
 
RNA sample buffer 
  Deionised Formamide   10 ml 
  37% Formaldehyde  3.5 ml 
  5x MOPS   2 ml 
Divide into 500 µl aliquots and store at -20
o
C. 
Use 2 parts sample buffer for each part of RNA. 
 
Denatured 1% agarose-formaldehyde gel 
Agarose   0.35 g 
0.1% DEPC-treated water : 5x MOPS : 37% Formaldehyde 
Ratio                        3.5     :       1.1      :       1 
 
                Cast the gel in the fumehood. Allow the gel to set at room temperature. 
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Appendix 3: Raw data of results 
 
Cell count of six clones 
 
 B5-P4      
      
Time (h)    Mean SD 
0 10000 10000 10000 10000 0 
24 10000 10000 10000 10000 0 
48 22000 44000 66000 44000 22000 
72 88000 77000 99000 88000 11000 
96 110000 110000 121000 113667 6350.853 
120 132000 132000 132000 132000 0 
144 143000 132000 154000 143000 11000 
168 165000 264000 66000 165000 99000 
192 187000 176000 176000 179667 6350.853 
216 220000 209000 220000 216333 6350.853 
240 198000 209000 209000 205333 6350.853  
  
  
  
 B12-P4      
      
Time (h)    Mean SD 
0 10000 10000 10000 10000 0 
24 10000 22000 22000 18000 6928.203 
48 22000 22000 33000 25666.67 6350.853 
72 44000 33000 22000 33000 11000 
96 55000 66000 44000 55000 11000 
120 66000 66000 55000 62333.33 6350.853 
144 88000 66000 77000 77000 11000 
168 99000 121000 55000 91666.67 33605.56 
192 121000 99000 110000 110000 11000 
216 110000 132000 132000 124666.7 12701.71 
240 132000 110000 121000 121000 11000  
  
  
  
 D4-P4      
      
Time (h)    Mean SD 
0 10000 10000 10000 10000 0 
24 22000 11000 22000 18333 6350.853 
48 55000 44000 66000 55000 11000 
72 66000 77000 55000 66000 11000 
96 88000 99000 77000 88000 11000 
120 99000 110000 110000 106333 6350.853 
144 110000 110000 121000 113667 6350.853 
168 121000 143000 110000 124667 16802.78 
192 121000 99000 154000 124667 27682.73 
216 132000 121000 132000 128333 6350.853 
240 121000 110000 143000 124667 16802.78  
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 D9-P4      
      
Time (h)    Mean SD 
0 10000 10000 10000 10000 0 
24 10000 10000 10000 10000 0 
48 22000 11000 22000 18333 6350.853 
72 22000 11000 33000 22000 11000 
96 55000 55000 44000 51333.33 6350.853 
120 66000 77000 99000 80666.67 16802.78 
144 88000 44000 110000 80666.67 33605.56 
168 110000 143000 121000 124666.7 16802.78 
192 165000 154000 165000 161333.3 6350.853 
216 242000 187000 286000 238333.3 49601.75 
240 242000 220000 253000 238333.3 16802.78  
  
  
  
  
 E1-P4      
      
Time (h)    Mean SD 
0 10000 10000 10000 10000 0 
24 11000 11000 11000 11000 0 
48 33000 44000 55000 44000 11000 
72 110000 66000 77000 84333 22898.33 
96 88000 99000 99000 95333 6350.853 
120 110000 143000 121000 124667 16802.78 
144 154000 143000 154000 150333 14620.76 
168 176000 176000 176000 176000 0 
192 242000 253000 231000 242000 11000 
216 253000 264000 242000 253000 11000 
240 253000 253000 242000 249333 6350.853  
  
  
  
  
 E8-P4      
      
Time (h)    Mean SD 
0 10000 10000 10000 10000 0 
24 10000 11000 10000 10333 577.3503 
48 11000 22000 11000 14667 6350.853 
72 22000 33000 22000 25667 6350.853 
96 33000 22000 33000 29333 6350.853 
120 44000 33000 55000 44000 11000 
144 66000 88000 55000 69667 16802.78 
168 77000 88000 66000 77000 11000 
192 88000 99000 77000 88000 11000 
216 88000 110000 99000 99000 11000 
240 88000 110000 88000 95333 12701.71  
  
 
 APPENDICES 106 
 
Statistical analysis: Doubling time of the six clones 
 
 
 B5 B12 D4 D9 E1 E8 
Number of values 3 3 3 3 3 3 
Minimum 25.9 38.4 24 33.6 26.4 28.8 
Median 26.4 43.2 25.4 33.6 26.9 28.8 
Maximum 26.9 48 27.8 33.6 27.36 28.8 
Mean 26.4 43.2 25.73 33.6 26.89 28.8 
Std. Deviation 0.5 4.8 1.922 0 0.4801 0 
Std. Error 0.2887 2.771 1.11 0 0.2772 0 
Lower 95% CI 25.16 31.28 20.96 33.6 25.69 28.8 
Upper 95% CI 27.64 55.12 30.51 33.6 28.08 28.8  
 
 
 
 One-way analysis of variance  (ANOVA)     
  P value P<0.0001     
  Are means signif. different? (P < 0.05) Yes     
  Number of groups 6     
  F 29.89     
  R squared 0.9257     
      
  ANOVA Table SS df MS   
  Treatment (between columns) 677.8 5 135.6   
  Residual (within columns) 54.43 12 4.536   
  Total 732.2 17    
      
      
  Tukey's Multiple Comparison Test Mean Diff. q P value 95% CI of diff 
  B5 vs B12 -16.8 13.66 P < 0.001 -22.64 to -10.96 
  B5 vs D4 0.6667 0.5422 P > 0.05 -5.175 to 6.508 
  B5 vs D9 -7.2 5.856 P < 0.05 -13.04 to -1.358 
  B5 vs E1 -0.4867 0.3958 P > 0.05 -6.328 to 5.355 
  B5 vs E8 -2.4 1.952 P > 0.05 -8.242 to 3.442 
  B12 vs D4 17.47 14.21 P < 0.001 11.62 to 23.31 
  B12 vs D9 9.6 7.808 P < 0.01 3.758 to 15.44 
  B12 vs E1 16.31 13.27 P < 0.001 10.47 to 22.16 
  B12 vs E8 14.4 11.71 P < 0.001 8.558 to 20.24 
  D4 vs D9 -7.867 6.398 P < 0.01 -13.71 to -2.025 
  D4 vs E1 -1.153 0.938 P > 0.05 -6.995 to 4.688 
  D4 vs E8 -3.067 2.494 P > 0.05 -8.908 to 2.775 
  D9 vs E1 6.713 5.46 P < 0.05 0.8716 to 12.56 
  D9 vs E8 4.8 3.904 P > 0.05 -1.042 to 10.64 
  E1 vs E8 -1.913 1.556 P > 0.05 -7.755 to 3.928  
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Mean grouping test 
 
 
Clone Mean Tukey grouping 
D4 25.40 A 
B5 26.40 A 
E1 26.89 A 
E8 28.80 AB 
D9 33.60 B 
B12 43.30 C 
 
 
Note:  
 
A ranked list of means (ascending order) and letter codes were used to illustrate 
groupings of the variation in Tukey’s test. Means with the same single letter code are 
not significantly different. Where two letter codes overlap, the means are not 
significantly different. In this case, B12 clone can be distinguished as significantly 
different from other clones. 
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Cell count of clones treated with or without extracellular ATP 
 
 
 
 
 
 B12 control (no ATP)     
      
Time (h)    Mean SD 
0 10000 10000 10000 10000 0 
12 10000 10000 10000 10000 0 
24 10000 10000 10000 10000 0 
36 11000 10000 11000 10666.67 577.3503 
48 22000 11000 11000 14666.67 6350.853 
60 33000 22000 33000 29333.33 6350.853 
72 55000 55000 22000 44000 19052.56 
96 55000 44000 55000 51333.33 6350.853 
120 66000 55000 44000 55000 11000 
144 66000 77000 88000 77000 11000 
168 88000 77000 77000 80666.67 6350.853 
192 99000 88000 77000 88000 11000 
216 88000 99000 88000 91666.67 6350.853 
240 110000 99000 110000 106333.3 6350.853  
  
  
  
  
  
  
 B12 treated with 50 µM ATP    
      
Time (h)    Mean SD 
0 10000 10000 10000 10000 0 
12 10000 10000 10000 10000 0 
24 10000 10000 11000 10333.33 577.3503 
36 11000 11000 11000 11000 0 
48 11000 22000 33000 22000 11000 
60 33000 22000 33000 29333.33 6350.853 
72 33000 66000 33000 44000 19052.56 
96 66000 55000 44000 55000 11000 
120 55000 88000 66000 69666.67 16802.78 
144 99000 66000 33000 66000 33000 
168 88000 99000 66000 84333.33 16802.78 
192 99000 99000 99000 99000 0 
216 110000 88000 132000 110000 22000 
240 110000 99000 121000 110000 11000  
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 B12 treated with 100 µM ATP    
      
Time (h)    Mean SD 
0 10000 10000 10000 10000 0 
12 11000 11000 10000 10666.67 577.3503 
24 11000 22000 11000 14666.67 6350.853 
36 44000 22000 44000 36666.67 12701.71 
48 33000 11000 44000 29333.33 16802.78 
60 55000 77000 88000 73333.33 16802.78 
72 88000 88000 88000 88000 0 
96 121000 99000 99000 106333.3 12701.71 
120 121000 121000 110000 117333.3 6350.853 
144 99000 132000 143000 124666.7 22898.33 
168 110000 154000 88000 117333.3 33605.56 
192 110000 165000 187000 154000 39661.06 
216 121000 121000 132000 124666.7 6350.853 
240 110000 99000 121000 110000 11000  
  
  
  
 B12 treated with 1 mM ATP    
      
Time (h)    Mean SD 
0 10000 10000 10000 10000 0 
12 11000 22000 11000 14666.67 6350.853 
24 11000 55000 44000 36666.67 22898.33 
36 44000 55000 55000 51333.33 6350.853 
48 55000 77000 66000 66000 11000 
60 110000 99000 99000 102666.7 6350.853 
72 110000 132000 132000 124666.7 12701.71 
96 121000 99000 121000 113666.7 12701.71 
120 143000 132000 132000 135666.7 6350.853 
144 154000 132000 110000 132000 22000 
168 121000 132000 132000 128333.3 6350.853 
192 110000 121000 143000 124666.7 16802.78 
216 110000 110000 121000 113666.7 6350.853 
240 143000 154000 110000 135666.7 22898.33  
  
  
  
 D4      
      
Time (h)    Mean SD 
0 10000 10000 10000 10000 0 
24 33000 22000 11000 22000 11000 
48 33000 55000 66000 51333.33 16802.78 
72 66000 55000 66000 62333.33 6350.853 
96 77000 66000 99000 80666.67 16802.78 
120 77000 99000 110000 95333.33 16802.78 
144 88000 110000 121000 106333.3 16802.78 
168 110000 132000 121000 121000 11000 
192 121000 132000 99000 117333.3 16802.78 
216 110000 143000 143000 132000 19052.56 
240 132000 121000 143000 132000 11000  
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Statistical analysis: Doubling time of the clones 
 
 
 
 
B12 
(no ATP) 
B12 
(50 µM ATP) 
B12 
(100 µM ATP) 
B12 
(1 mM ATP) 
D4 
 
Number of values 3 3 3 3 3 
Minimum 38.4 33.6 19.2 14.4 21.6 
Median 40.8 36 21.6 14.4 24 
Maximum 43.2 38.4 24 16.8 24 
Mean 40.8 36 21.6 15.2 23.2 
Std. Deviation 2.4 2.4 2.4 1.386 1.386 
Std. Error 1.386 1.386 1.386 0.8 0.8 
Lower 95% CI 34.84 30.04 15.64 11.76 19.76 
Upper 95% CI 46.76 41.96 27.56 18.64 26.64  
 
 
 
 
 
One-way analysis of variance (ANOVA)     
  P value P<0.0001     
  Are means signif. different? (P < 0.05) Yes     
  Number of groups 5     
  F 80.55     
  R squared 0.9699     
      
      
      
      
  ANOVA Table SS df MS   
  Treatment (between columns) 1361 4 340.2   
  Residual (within columns) 42.24 10 4.224   
  Total 1403 14    
      
      
      
      
  Tukey's Multiple Comparison Test 
Mean 
Diff. q P value 95% CI of diff 
  B12 no ATP vs B12 - 50µM ATP 4.8 4.045 P > 0.05 -0.7224 to 10.32 
  B12 no ATP vs B12 - 100µM ATP 19.2 16.18 P < 0.001 13.68 to 24.72 
  B12 no ATP vs B12 - 1mM ATP 25.6 21.57 P < 0.001 20.08 to 31.12 
  B12 no ATP vs D4 17.6 14.83 P < 0.001 12.08 to 23.12 
  B12 - 50µM ATP vs B12 - 100µM ATP 14.4 12.14 P < 0.001 8.878 to 19.92 
  B12 - 50µM ATP vs B12 - 1mM ATP 20.8 17.53 P < 0.001 15.28 to 26.32 
  B12 - 50µM ATP vs D4 12.8 10.79 P < 0.001 7.278 to 18.32 
  B12 - 100µM ATP vs B12 - 1mM ATP 6.4 5.394 P < 0.05 0.8776 to 11.92 
  B12 - 100µM ATP vs D4 -1.6 1.348 P > 0.05 -7.122 to 3.922 
  B12 - 1mM ATP vs D4 -8 6.742 P < 0.01 -13.52 to -2.478  
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Mean grouping test 
 
 
Clone Mean Tukey grouping 
B12 with 1 mM ATP 15.20 A 
B12 with 100 µM ATP 21.60 B 
D4 (no ATP) 23.20 B 
B12 with 50 µM ATP 36.00 C 
B12 (no ATP) 40.80 C 
 
 
Note:  
 
A ranked list of means (ascending order) and letter codes were used to illustrate 
groupings of the variation in Tukey’s test. Means with the same single letter code are 
not significantly different. Where two letter codes overlap, the means are not 
significantly different. In this case, B12 clone treated with 1 mM ATP can be 
distinguished as significantly different from other clones. 
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Quantitation of mitochondria 
 
A standard curve of absorbance against BSA concentration was plotted using 
Microsoft
®
 Windows
®
 Excel 2003 software. A best-fit line in the form of the equation 
‘y = mx + b’ (where y = absorbance at 595 nm and x = protein concentration) was 
drawn. This equation was used to calculate the concentration of the protein sample 
based on the measured absorbance. 
 
 
 
Bradford Protein Assay
y = 0.0002x + 0.059
R2 = 0.9641
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